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Generation and Characterization of an Attenuated Mutant in a Response-Regulator 
Gene of Francisella Tularensis Live Vaccine Strain (LVS) 
Wendy L. Sammons 
ABSTRACT 
 
Francisella tularensis is a zoonotic bacterium that must exist in diverse 
environments ranging from arthropod vectors to mammalian hosts.  To better understand 
how genes are regulated in these different environments, a transcriptional response- 
regulator gene (genome locus FTL0552) was deleted in F. tularensis live vaccine strain 
(LVS).   The FTL0552 deletion mutant exhibited slightly reduced rates of extracellular 
growth but was unable to replicate or survive in mouse macrophages and was avirulent in 
the mouse model using either BALB/c or C57BL/6 mice.  Mice infected with the 
FTL0552 mutant produced reduced levels of inflammatory cytokines, exhibited reduced 
histopathology and cleared the bacteria quicker than mice infected with LVS.  Mice that 
survived infection with the FTL0552 mutant were afforded partial protection when 
challenged with a lethal dose of the virulent Schu S4 strain (4 of 10 survivors, day 21 
post infection) when compared to naïve mice (0 of 10 survivors by day 7 post infection).  
Microarray experiments indicate that 148 genes are regulated in the FTL0552 mutant. 
Most of the genes are down regulated, indicating that FTL0552 controls transcription of 
genes in a positive manner.  The list of down regulated genes includes genes located 
 viii
within the Francisella Pathogenicity Island (FPI) that are essential for intracellular 
survival and virulence of Francisella tularensis.  Furthermore, a mutant in FTL0552 or 
the comparable locus in Schu S4 (FTT1557c) may be an alternative candidate vaccine for 
tularemia. 
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Introduction 
 
Francisella Species 
Francisella tularensis is a small, non-motile, aerobic, gram-negative cocco-
bacillus, the only genus belonging to the Family Francisellaceae and a member of the γ-
subclass of proteobacteria.  This bacterium was first discovered by McCoy and Chapin in 
1911 following an outbreak of a plague-like illness in ground squirrels in Tulare County, 
California.  There are two species within the Francisella genus:  tularensis and 
philomiragia (26, 44, 58).  These bacteria are hardy, non-spore forming organisms, with a 
thin lipopolysaccharide-containing envelope that can persist in the environment for long 
periods of time in low temperature water, moist soil, hay, straw, and decaying animal 
carcasses (www.bt.cdc.gov/agent/tularemia) (58).  There are five subspecies of F. 
tularensis found in the Northern Hemisphere but only two subsp., tularensis and 
holarctica, cause human disease (58).  The most virulent subsp., tularensis (type A), is 
the causative agent of the zoonotic disease, tularemia.  It is predominantly found in North 
America and is associated with lethal pulmonary infections.  Recently, studies further 
divided the subsp. tularensis into two genetically distinct clades, type A1, found 
predominantly in California, the midwest and Massachusetts, and A2, found 
predominantly in California and the mountain states (58).  The second subsp. holarctica 
(type B), also known as palearctica, rarely causes a fatal disease in humans and is 
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predominantly found in Europe and Asia. An attenuated Live Vaccine Strain (LVS), 
derived from a Russian strain of subsp. holarctica, has been described and shown to offer 
protection to humans against naturally and laboratory acquired tularemia but remains as 
virulent to mice as wild type subsp. holarctica (35).  LVS causes disease in mice that is 
virtually indistinguishable from that caused in humans by the highly virulent strains (5, 
21, 29).  The LVS strain is not fully licensed as a vaccine but is currently under review by 
the U.S. Food and Drug Administration.  It has been used as an investigational new drug 
for persons at high risk for tularemia such as scientists working with F. tularensis.  The 
third subsp., novicida, has been characterized as a relatively non-virulent strain, with only 
two documented cases of tularemia caused by novicida in two severely 
immunocompromised patients in North America.  The most recently identified subsp. of 
Francisella is mediasiatica. It is primarily found in Asia but very little is know about this 
subsp. or its association with human disease.  F. philomiragia is a muskrat pathogen (58).   
 
Francisella tularensis and Human Disease 
F. tularensis is capable of infecting many invertebrates and vertebrates.  Recent 
discoveries revealed that F. tularensis is resistant to killing by the free-living amoebae, 
Acanthamoeba castellanii, and this protozoa is the suspected source of outbreaks of 
gastrointestinal and respiratory tularemia in humans in Norway (1, 8, 58). Humans can be 
incidentally infected through direct contact with infected mammalian reservoirs or 
through vectors such as ticks, mosquitoes, and deer flies.  The most important 
mammalian species responsible for human infection include muskrats, beavers, squirrels, 
mice, voles (meadow or field mice) and lagomorphs (hares, rabbits and pikas) (58).  
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There are no cases of human-to-human transmission documented.  The most common 
form of the disease is ulceroglandular, which occurs through direct skin contact.  
Consumption of contaminated food or water can lead to an oropharyngeal infection and 
inoculation of the eye can lead to a conjunctival infection.  The most severe form of 
disease, pneumonic tularemia, develops from the inhalation of aerosolized bacteria, often 
generated when handling infected animal carcasses, leading to the common reference to 
the disease as rabbit fever.  Brushcutting and lawn mowing or disturbing contaminated 
areas can generate aerosolization of the bacteria.  Worldwide incidence of naturally 
occurring tularemia is unknown.  In the U.S., reported cases have dropped sharply from 
several thousand/year prior to1950 to fewer than 200/year in the 1990s (58).   
 
F. tularensis Pathogenesis and Treatment 
 F. tularensis can infect humans through the skin, mucous membranes, 
gastrointestinal tract, and lungs. It is a facultative intracellular bacterium that multiplies 
within macrophages. Within the macrophage, the bacteria are capable of replicating to 
high numbers before the onset of a protective cell-mediated immune response, a hallmark 
of tularemia (35).  The major target organs are the lymph nodes, lungs and pleura, spleen, 
liver, and kidney. Untreated, bacilli inoculated into skin or mucous membranes multiply, 
spread to regional lymph nodes, and further multiply, and then may disseminate to organs 
throughout the body.  Bacteremia may be common in the early phase of infection. The 
initial tissue reaction to infection is a focal, intensely suppurative necrosis consisting 
largely of accumulations of polymorphonuclear leukocytes, followed by invasion of 
macrophages, epithelioid cells, and lymphocytes.  Suppurative lesions become 
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granulomatous, and histopathological examination of the granulomas shows a central 
necrotic, sometimes caseating, zone surrounded by a layer of epithelioid cells, 
multinucleated giant cells, and fibroblasts in a radial arrangement, typical of other 
granulomatous conditions such as tuberculosis and sarcoidosis.  Humans with 
inhalational exposures also develop hemorrhagic inflammation of the airways early in the 
course of illness, which may progress to bronchopneumonia. Histopathological 
examination of the lungs shows alveolar spaces filled with an exudate of mononuclear 
cells. Pleuritis with adhesions and effusion and hilar lymphadenopathy are common in 
radiological and pathological findings.  Primary clinical forms vary in severity and 
presentation according to virulence of the infecting organism, dose, and site of inoculum.  
The onset of tularemia is usually abrupt, with fever (38oC40oC), headache, chills and 
rigors, generalized body aches (often prominent in the lower back), coryza, and sore 
throat. Pulse-temperature dissociation has been noted in as many as 42% of patients. A 
dry or slightly productive cough and substernal pain or tightness frequently occur with or 
without objective signs of pneumonia, such as purulent sputum, dyspnea, tachypnea, 
pleuritic pain, or hemoptysis. Nausea, vomiting, and diarrhea may occur.  Sweats, fever, 
chills, progressive weakness, malaise, anorexia, and weight loss characterize the 
continuing illness (www.bt.cdc.gov/agent/tularemia).  
Tularemia is treatable with antibiotics, with streptomycin as the drug of choice.  
However, the time of onset of treatment and the route of infection determines the severity 
and form of disease progression.  Up to 60% of untreated infections can be fatal (58).  
Gentamicin, which is more widely available and can be used intravenously, is an 
acceptable alternative. Treatment with aminoglycosides should be continued for 10 days. 
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Tetracyclines and chloramphenicol are also used, but relapses and primary treatment 
failures occur at a higher rate with these bacteriostatic agents than with aminoglycosides, 
and they should be given for at least 14 days to avoid relapse. Both streptomycin and 
gentamicin are recommended as first-line treatment of tularemia in children.  In a mass 
casualty setting, doxycycline and ciprofloxacin, administered orally, are the preferred 
choices for treatment of both adults and children (www.bt.cdc.gov/agent/tularemia).  
 
F. tularensis Live Vaccine Strain (LVS) 
A live vaccine strain (LVS) has been used for immunization in the past, but is not 
licensed for general use and does not provide complete protection (71).  Problems with 
the LVS include its failure to induce full immunity against all forms of tularemia (10), 
and the effects of culture conditions on its attenuation (14).  Although the origin and 
source of the attenuation are not known, recent data suggest a possible genetic basis for 
the reduced virulence of the LVS strain (70).  The findings were based on identification 
of sequence variations from comparisons between the genome of LVS to the closely 
related strain, F. tularensis holarctica strain FSC200.   
 
F. tularensis as a Bioweapon 
 Francisella tularensis has been classified by the United States Centers for Disease 
Control and Prevention (CDC) Strategic Planning Group as a Category A agent of high 
priority (37).   F. tularensis is a candidate for bioterrorism because of its virulence, low 
infective dose, and its potential for transmission by aerosols (37).  In humans, an 
infectious dose for type A strains can be as low as 10 bacteria for respiratory (57, 75)  or 
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intradermal routes (76).  In addition to naturally occurring outbreaks reported since the 
mid-twentieth century, it is suspected that Japanese germ warfare research units studied 
and may have deliberately used F. tularensis subsp. tularensis against Chinese civilians, 
Russian troops and American prisoners of war between 1932 and 1945 (42, 58).  Both the 
United States and Russia stockpiled tons of infectious agents, including F. tularensis 
subsp. tularensis, for potential use a bioweapons during the cold war (15, 42, 58). 
 
F. tularensis Virulence Factors 
Little is known about virulence mechanisms of F. tularensis  (60, 78).  
Francisella species are facultative intracellular pathogens that can survive phagocytosis 
and multiply within host macrophages (27, 73, 77).  The ability of Francisella species to 
survive and multiply in macrophages plays a crucial role in its dissemination and 
pathogenesis (4, 27).   Immunity to F. tularensis infection is afforded primarily by a cell-
mediated response (33, 78), and is not induced by immunization with killed bacteria (83, 
84).   
 
Lipopolysaccharide (LPS) 
Unlike E. coli lipopolysaccharide (LPS), F. tularensis LPS does not activate cells 
to release pro-inflammatory cytokines via TLR4 and is 1000-fold less potent than LPS 
from other enteric bacteria.  Recent studies suggest that unique structural features within 
the F. tularensis LPS lipid A backbone and core structure, as well as the insertion 
element (IS-Ftu1) contained within the O-antigen gene cluster are responsible for the 
phase variation and low bioactivity of Francisella LPS (Fig. 1) (3, 18, 46, 58, 72, 85, 90).    
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Figure 1.  Structure of F. tularensis LPS.  The lipid A of F. tularensis subsp. holarctica 
strain 1547. Note the asymmetrical lipid A structure and the absence of O-acylation on 
hexosamine II (arrow). The phosphogalactosamine substitution on the 
4'-position of this hexosamine is also unique to Francisella (McLendon, M.K., M.A. 
Apicella, and L.A. Allen, 2006). 
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Type IV Pili 
Type IV pili, on the surface of bacteria, help mediate attachment to host cells, 
DNA uptake, twitching motility and biofilm formation.  Microscopy revealed structures 
resembling type IV pili on the surface of F. tularensis LVS and orthologs of genes 
required for expression of the type IV pilus are present in the F. tularensis subsp. 
tularensis Schu S4 genome.  Deletion of the type IV pilin gene resulted in attenuated 
virulence of the bacteria (25).  However, the role of Francisella pili has yet to be 
determined (11, 12, 31, 52, 58, 67).  Although F. tularensis does not appear to secrete 
toxins, homologs of pilin and pseudopilin genes associated with type II secretion, along 
with 15 potential ATP-binding cassette system genes that may be involved in type I 
secretion are present in the genome sequence of F. tularensis Schu S4 (31, 52, 58).     
 
Francisella Pathogenicity Island (FPI)    
The F. tularensis subsp. tularensis Schu S4 genome is approximately 1.9 Mb, 
containing 1804 predicted coding sequences.  More than 10% of the genes are 
pseudogenes or gene fragments and there are five insertion elements scattered throughout 
the genome, resulting in the disruption of more than half of the predicted metabolic 
pathways (52, 58, 86).  There is a unique 33.9-kb region, encoding 25 genes with no 
known homologs, that is duplicated within the Schu S4 genome and is also present in 
LVS and F. tularensis subsp. novicida.  Disruption of genes within this region results in 
attenuation of the bacterias ability to survive within host macrophages.  The region is 
termed the Francisella Pathogenicity Island (FPI) (34, 36, 51, 52, 65). 
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Intracellular Survival 
F. tularensis infects macrophages of humans, mice, rats, rabbits and guinea pigs. 
Macrophages are believed to be the primary host cell for survival and replication of the 
bacterium.  Internalization of F. tularensis occurs via phagocytosis, mediated by large 
asymmetric pseudopod loops projecting from the surface of the macrophage that encircle 
the attached bacteria (16, 58).  However, the exact niche occupied by this organism and 
the specific virulence factors modulating the organisms intracellular growth and survival 
are not clearly defined (58).  Once internalized, bacteria are maintained within a 
phagosomal compartment, which would normally undergo a series of interactions with 
early endosomes, late endosomes, and lysosomes to lead to the degradation of the 
ingested bacteria.  In contrast, LVS phagosomes transiently associate with early 
endosomes, accumulate the late-endosome markers lamp-1, lamp-2, and CD63, but do 
not mature further and do not acquire lysosomal hydrolases.  At 3 to 4 hours following 
ingestion, the late endosome markers, lamp-1 and CD63 begin to decline, the phagosome 
membrane is disrupted and by 6 hours following ingestion, the bacteria begin to replicate 
in the cytosol (Fig. 2) (2, 4, 17, 28, 32, 58, 74).  How the phagosome membrane is 
disrupted is yet to be defined.  Recent studies identified a 23-kDa protein, encoded by the 
intracellular growth locus (iglC) whose expression is up-regulated in macrophages.  The 
iglC gene is located within the IglABCD gene cluster that is a major component of the 
FPI (34, 58, 65).  The expression of FPI genes required for intramacrophage survival, 
including iglB and iglC, is controlled by the macrophage growth locus A and B (MglA 
and MglB) (54).  MglA and MglB are transcriptional regulators controlling the 
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expression of virulence genes.  Introduction of a mglA mutation into F. tularensis subsp. 
novicida identified 102 genes regulated by this factor alone (9). 
Mutants in mglA, mglB, iglB, and iglC do not escape the phagosome, are impaired in 
intracellular macrophage growth and are dramatically reduced in virulence in a mouse 
model (7, 35, 36, 51, 54, 74).    
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Figure 2.  Francisella tularensis phagocytosis and trafficking within the endocytic 
pathway. Following bacterial engulfment, the phagosome particles first matures to an 
early endosome (pH ~6.5) expressing Rab5 and EEA1, and then to a late endosome 
expressing Rab7, Lamps, and M6PR. The non-acidified late-endosome-like phagosome 
of Francisella tularensis does not fuse with lysosomes and is stable for 2-4 h, followed 
by gradual disruption and bacterial escape into the cytoplasm, where replication occurs. 
(www.biohealthbase.org/GSearch/imgs/image004.gif) 
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Two-Component Signal Transduction Sytems (TCS)           
The pathogen-host relationship is complex, and successful infection depends upon 
the expression of a number of bacterial genes that are adapted for infection of the host 
(23, 24, 43, 48).   In the case of the vector-borne zoonotic bacterium F. tularensis, it must 
survive and grow under a wide range of conditions including arthropod vectors, such as 
ticks, as well as in warm-blooded vertebrate hosts.   The synthesis of bacterial virulence 
factors in these changing environments is highly regulated and responds to environmental 
cues such as growth phase, temperature, osmotic stress and changing concentration of 
extracellular ions such as Mg2+, Ca2+ and Fe2+ (59).   Two component signal transduction 
systems (TCS), reviewed by Stock et al. (82), are the most prevalent strategies bacteria 
use to couple environmental signals to adaptive responses, and play an important role in 
bacterial survival under environmental stress including survival within macrophages (61).  
They typically contain a membrane bound sensor kinase and a cytoplasmic response-
regulator.  The sensor kinase detects environmental signals at the surface of the cells, 
resulting in autophosphorylation of a histidine residue in the cytoplasmic C-terminal tail.  
The response-regulator is comprised of two highly conserved domains, the 
regulatory/receiver domain and the effector domain (Fig. 3A).  The receiver domain acts 
as a phosphorylation-activated switch that controls an associated effector domain.  The 
sensor kinase transfers the phosphate group to a conserved active-site aspartic acid 
residue within the cytoplasmic response-regulator receiver domain, shifting the 
equilibrium to an active state.  Phosphorylation modifies the effector domains ability to 
act as a DNA-binding, transcription activator controlling multiple genes (Fig. 3B) (79, 
81).  Inactivation of two component signal transduction systems results in reduced 
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bacterial virulence (38). For example, Salmonella phoP/phoQ genes control the 
expression of more than 40 genes, including proteins encoded by virulence-associated 
genes important for intramacrophage survival during infection (55, 62).   The PhoQ 
sensor kinase responds to changes in external stimuli, including magnesium 
concentrations, to activate the PhoP response-regulator, and results in the transcription of 
genes essential for survival of the bacteria in the changing environment (79).  PhoP also 
controls virulence in Yersinia pestis (68), Shigella flexneri (64), Myocobacterium 
tuberculosis (69), Bordetella pertussis (47), and N. meningitidis (45, 66).   A TCS 
response-regulator, PmrA has been recently described in Francisella tularensis subsp. 
novicida.  PmrA is an orphan member of typical two-component regulatory systems.  
PmrA shares high similarity (44%) with the Salmonella PmrA response-regulator.  F. 
novicida mutants lacking the pmrA gene were defective for survival and growth within 
macrophages and offer complete protection in mice against homologous challenge but 
did not protect the mice against challenge with the Schu S4 strain.  DNA microarray 
analysis identified 65 genes regulated by PmrA, some of which are located within the FPI 
(63). 
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Figure 3.  TCS.  (A) F. tularensis FTL0552 response-regulator conserved signal receiver 
and effector domains.  (B) The sensor kinase detects environmental signals at the surface 
of the cells, resulting in autophosphorylation.  The sensor kinase transfers the phosphate 
group to a conserved active-site aspartic acid residue within the cytoplasmic response-
regulator receiver domain, modifying the effector domains ability to act as a 
transcription activator for several genes 
(www.bio.vu.nl/hwconf/IntrBCA00/img052.GIF). 
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Objectives 
 
Very little is known about the molecular mechanisms of F. tularensis 
pathogenesis (53). A live vaccine strain (LVS) has been used for immunization in the 
past, but has failed to induce full immunity against laboratory acquired tularemia and is 
not approved for use against the disease (10, 89).  The LVS is an attenuated strain of F. 
tularensis subsp. holarctica (type B).  The reasons for attenuation and immunological 
basis for the efficacy of the LVS strain are not fully understood (53, 78, 87, 89).  
Immunity to F. tularensis infection is a cell-mediated immunity, with a very complex 
pathogen-host relationship (23, 24, 48).  Successful infection depends on the coordinated 
expression of bacterial genes in response to the host cell environment (43).  F. tularensis 
is able to respond to and exploit host cell functions in a process that avoids phagocytosis 
and permits the bacteria to survive and replicate within the host cell (53).  The genes that 
facilitate the survival and replication of Francisella within the host cell play a crucial role 
in pathogenesis.  In Francisella tularensis, they are part of a very highly regulated system 
that is adapted to respond to environmental cues such as growth phase, temperature, 
changes in metal ion concentrations, and pH (56, 59).   
Bacterial survival within macrophages is highly dependent on genetic systems 
that respond to environmental stress (91).  Two component genetic systems have been 
shown to be important for bacteria experiencing environmental stress by mediating signal 
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transduction necessary to allow survival within macrophages (38, 61).  Inactivation of 
two component signal transduction systems results in changing the cell physiology and 
modulating transcriptional activation of critical virulence genes (38, 61).   
The S. typhimurium PhoPQ system has been the most widely studied two-component 
signal transduction system (38, 61, 69, 91).   
Bioinformatics revealed a putative phoP coding sequence in F. tularensis LVS 
with significant homology to a consensus PhoP amino acid sequence derived from the 
alignment of PhoP from other Gram-negative bacteria.  Subsequent sequencing of the 
LVS genome sequence identified a potential two-component response-regulator 
(FTL0552).   
The generation of a mutant F. tularensis strain that may be significantly reduced 
in virulence but still able to produce an immune response will be useful in the 
development of an improved live vaccine strain licensed for use against tularemia. 
Hypothesis:  Locus FTL0552 of Francisella tularensis LVS controls transcription of 
genes whose products are necessary for the full virulence of this bacterium.  The 
following aims were developed in order to refute or support this hypothesis. 
AIM 1  Construct a knockout mutant in the F. tularensis LVS FTL0552.  Determine if 
the mutant has altered phenotypic properties similar to those predicted for the phoP gene 
from other Gram-negative bacteria. 
A.  Construct a mutagenic plasmid that will be introduced into the recipient strain    
      by conjugation with selection for the inactivated phoP gene and allelic  
      replacement of the wild-type gene with the mutant allele. 
B.  Determine the growth properties for the mutant. 
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C.  Analyze the response to varying levels of Mg2+ as compared to the wild type. 
D.  Analyze in vitro susceptibility to antimicrobial peptides and pH changes as 
compared to wild type. 
AIM 2  Examine the FTL0552 mutant to analyze the role F. tularensis LVS FTL0552 
plays in pathogenicity and immunogenicity. 
A. Perform in vitro survival and replication studies in macrophages. 
B. Perform in vivo studies to determine the ability of the mutant to cause disease 
in a mouse model. 
a. Perform time to death study of mice infected with the mutant. 
b. Perform bacterial clearance studies. 
c. Perform histopathological evaluation. 
C. Determine if the mutant is able to confer protection of infected mice. 
a. Challenge the infected mice with LVS and the fully virulent strain. 
b. Determine the cytokine profile of infected mice. 
AIM 3  Identify F. tularensis LVS genes whose expression is controlled by FTL0552. 
A. Perform gene microarray studies for mutant and LVS wild type. 
B. Compare cell lysate and supernatant proteins in LVS wild type and mutant.  
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Materials and Methods 
 
Bacterial Strains. 
F. tularensis LVS, kindly provided by Scott Bearden, CDC, Fort Collins, CO, was 
grown on agar consisting of GC agar base (Remel, Lenexa, KS) supplemented with 5% 
fetal bovine serum, 1% bovine hemoglobin and 1% IsoVitaleXTM (Becton Dickinson, 
Sparks, MD), incubated at 37ºC.  The F. tularensis LVS FTL0552 mutant was grown on 
the same agar with the addition of 50µg/ml kanamycin.  For some experiments, bacteria 
were grown in Mueller Hinton II (MH) broth (Becton Dickinson, Sparks, MD) 
supplemented with 0.1% glucose, 2% IsoVitaleXTM and 33 µM ferric pyrophosphate 
(56).  For bacterial growth analysis, MH broth cultures were incubated at 37ºC with 
aeration and the OD550 was measured at various time points. 
 
Cell Lines. 
 The immortalized mouse macrophage cell line (J774A.1) was cultured in 
Dulbeccos Modification of Eagles Medium (DMEM), supplemented with 10% fetal 
bovine serum (FBS), 4.5g/mL glucose and L-glutamine, and 50µg/ml penicillin-
streptomycin.  Mouse peritoneal exudate cells (PEC) were collected from thioglycolate 
treated BALB/c mice, washed and resuspended in medium containing, 10% FBS, 0.33 
µl/ml 2-mercaptoethanol, and L-glutamine.  
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Construction of pPVNot/Erm.   
A plasmid derivative of pPV was constructed that has an added Not I restriction 
site and has the erythromycin resistance gene (ErmR) substituted for chloramphenicol 
resistance (CmR).   To accomplish this task pPV shuttle vector (CmRApR) was kindly 
supplied by Drs. I. Golovliov and Anders Sjöstedt (35).  This plasmid was used to 
transform an E. coli DH5α recipient to chloramphenicol resistance.  pPV DNA was 
prepared from an E. coli DH5α transformant, and subsequently altered to introduce a Not 
I cloning site.  The pPV vector has unique Sal I and Xba I cloning sites.  An adaptor was 
designed that could be ligated to Sal I and Xba I cleaved pPV DNA to generate a Not I 
site.   Oligonucleotides P327 and P328 were annealed to produce adaptors (Table 1), and 
were ligated into pPV that had been cleaved with both Sal I and Xba I and transformed 
into E. coli DH5α with selection for chloramphenicol resistance. The presence of the NotI 
site was confirmed by restriction analysis and the resulting plasmid designated pPVNot. 
This resulted in a mobilizable plasmid with unique Not I, Sal I and Xba I sites.   A 
derivative of pPVNot was constructed that had the CmR marker replaced with ErmR.  
pPVNot was partially digested with Hind III, re-ligated and transformed into E. coli 
DH5α with selection for ampicillin resistance.  Colonies were screened for the loss of 
chloramphenicol resistance and the loss of (only) the 3.2 kb Hind III fragment which 
carries Cm resistance. This plasmid (ApR, CmS) was linearized by partial digestion with 
Hind III, and ligated to the ermC gene from pKS65.  pKS65, the source of ermC was 
generously provided by Dr. Joseph Dillard (41), (University of Wisconsin Medical 
School Madison, WI).  Transformants were scored for both ampicillin and erythromycin 
resistance on LB agar plates containing 200 µg/ml erythromycin and 100 µg/ml 
 20
ampicillin.  The resulting plasmid was designated pPVNot/Erm and this plasmid was 
used for gene transfer into F. tularensis LVS. 
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Table 1.  Oligonucleotides used in this study. 
Oligonucleotide 
 
Purpose/comments 
 
Sequence 5 to 3 
 
P327 Forms adaptor with P328 to introduce Not I site into pPV1 TCGACATGCGGCCGCATT 
P328 Forms adaptor with P327 to introduce Not I site into pPV1 CTAGAATGCGGCCGCATG 
Left-F 
Amplify 5 flanking region 
upstream of FTL0552, contains 
Not I site 
GCGCGGCCGCGACTCATTCAGTATCTGGGA 
Left-R 
Amplify 5 flanking region 
upstream of FTL0552, 5 
overhang of primer contains 
kanR sequences 
CGGCAAGAAAGCCATCCAGTCATCTTCAGCCAACAATATTC
TCAT 
Right-F 
Amplify 3 flanking region 
downstream of FTL0552, 5 
overhang of primer contains 
kanR sequences 
GCGGGACTCTGGGGTTCGAAAGGTGTTGGTTACTTTGTACA
AAAGG 
Right-R 
Amplify 3 flanking region 
downstream of FTL0552, 
contains Not I site 
GCGCGGCCGCTGGGACTCTAAGGTTTTCAA 
Kan-F Amplify the kan
R gene from 
PBBR1MCS2 ACTGGATGGCTTTCTTGCCG 
Kan-R Amplify the kan
R gene from 
PBBR1MCS2 TTTCGAACCCCAGAGTCCCGC 
FTL0552-F 
Amplify region within FTL0552 
gene to confirm gene knockout 
and for RT-PCR 
TTCAGATGGTGAGGCAGCGCAAA 
FTL0552-R 
Amplify region within FTL0552 
gene to confirm gene knockout 
and for RT-PCR 
CTTTGGTTACCGTTTCAGAGCTTGG 
FTL0552+1100-F 
Amplify region outside area of 
recombination to confirm 
integration of FTL0552::kanR in 
the chromosome 
CGGTGCAAAGACAGGAAAAC 
FTL0552+1100-R 
Amplify region outside area of 
recombination to confirm 
integration of FTL0552::kanR in 
the chromosome 
GTGACCGCCCTGTTCACTA 
lepB-F Amplify gene downstream of FTL0552 for RT-PCR GCTGATCAGGCGAGATCTTT 
lepB-R Amplify gene downstream of FTL0552 for RT-PCR AATTACATCGCCAGGCAAAC 
rnr-F Amplify gene downstream of FTL0552 for RT-PCR ACCAAGCTAGGCAAGAACGA 
rnr-R Amplify gene downstream of FTL0552 for RT-PCR TGCTAAAGCTTTGGGAGTCA 
mutS-F House keeping gene for RT-PCR GTGGCGTCATCAAAGAAGGT 
mutS-R House keeping gene for RT-PCR CGGGCTAGCGCCTTTTCTTT 
Operon 1-F Overlapping FTL0552 and lepB AGACTATTAGAGGTGTTGGTTACTTTG 
Operon 1-R Overlapping FTL0552 and lepB CTCATGTTTAACTCCATCAAGGTTT 
Operon 2-F Overlapping lepB and rnc AATGTTGACAATAAATGGTAAAAAACT 
Operon 2-R Overlapping lepB and rnc TCGATATTATTGGCTGATACCATTT 
Operon 3-F Overlapping rnc and truB TTGGCTGAAGGAAAACTATCG 
Operon 3-R Overlapping rnc and truB AGAGGTTGTCCATTATATTTAAGAGCT 
Operon 4-F Overlapping truB and rnr AAGCATTAACATTCCTGAGTTATCTG 
Operon 4-R Overlapping truB and rnr TGCACCCAAACGATTTACAA 
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Identification of the FTL0552 response-regulator gene.    
Bacterial PhoP protein sequences were retrieved from (NCBI) GenBank and 
aligned using the PileUp Program for aligning multiple sequences from the Genetics 
Computer Group (GCG) Wisconsin Package Version 10) (19, 22).  The consensus 
sequence, generated from the alignment of bacterial PhoP proteins, was used to search 
the TIGR Comprehensive Microbial Resource (CMR) with the PhoP consensus sequence.  
This search brought up PhoP proteins and confirmed the specificity of the consensus 
sequence.  A gapped BLAST search (3) of the Schu S4 and LVS genomes with the 
consensus sequence identified candidate phoP genes.  A phoP homologue was identified 
with 26% identical deduced amino acid sequences and shown to have motifs consistent 
with response-regulator proteins, containing both a response-regulator receiver domain 
and a transcriptional regulatory protein domain.  This amino acid sequence is highly 
conserved in the Schu S4 (FTT1557c) genomic sequence.   
 
Construction of the pPV-FTL0552 knockout plasmid.   
A modified version of a previously described method using PCR products to 
generate a knockout plasmid was used (53, 80).  The flanking sequence consisting of 
approximately 700 bp upstream and 700 bp downstream of FTL0552 were amplified 
from F. tularensis LVS genomic DNA in two separate PCR reactions, using EasyStart 
100 pre-aliquoted PCR reagents (Molecular BioProducts, San Diego, CA).  The primer 
sequences for the 5 flanking regions were Left-F and Left-R and the primer sequences 
for the 3 flanking sequences were Right-F and Right-R (Table 1).   A third PCR product 
consisting of the kanamycin resistance gene was amplified from pBBR1MCS2 (49), 
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using primers Kan-F and Kan-R.  All three products were gel-purified using Geneclean 
Turbo (MP Biomedicals, LLC., Solon, OH) and were used as templates in a PCR reaction 
to generate a single product with upstream and downstream flanking regions of FTL0552 
and most of the coding region (including nucleotides 26-645) replaced with kanR (Fig. 4).  
This PCR product was generated using primers Left-F and Right-R and is flanked by Not 
I restriction sites.  The entire PCR product was 2349 base pairs in length. The resulting 
PCR product was cleaved with Not I and ligated into the Not I site of pPVNot/Erm and 
transformed into E. coli JM109.  Plasmid DNA was prepared with the GenElute HP 
Plasmid Midiprep Kit (Sigma, St. Louis, MO).  The plasmid construct was confirmed by 
digestion with Not I and then transformed into E. coli S17-1.   
 
Delivery of FTL0552::kanR into F. tularensis LVS.   
A previously described strategy for allelic replacement was used (35).  The 
resulting plasmid with the FTL0552 coding sequence interrupted by the kanR gene was 
introduced into E. coli S17-1 for mobilization and transfer to LVS (Fig. 4).  Conjugation 
and selection were performed on supplemented GC agar plates containing 100µg/mL 
polymyxin B and 25µg/mL kanamycin.  Isolated colonies were spotted on plates 
containing 5% sucrose, kanamycin (25 µg/ml), and polymyxin B (100 µg/ml) for 
counterselection with sacB. Colonies that were both kanamycin and sucrose resistant 
were verified by PCR and used for further analysis.   
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Figure 4.  Schematic representation of the strategy used for generation of the 
FTL0552 deletion mutants.  The 5 and 3 flanking regions of FTL0552 gene were 
amplified from the F. tularensis LVS genomic DNA.  The primers used for the 
amplification of the regions flanking the FTL0552 gene regions and kanamycin 
resistance gene (kanR) were designed with short overlapping sequences to the kanR gene 
derived from pBBR1MCS2 (28).  The resulting three amplicons were gel-purified and 
used as template to amplify a PCR product with the kanR gene replacing FTL0552 (PCR 
product #4).  This product was digested with NotI and ligated into the suicide plasmid 
pPVNotErm (see text). The resulting plasmid was introduced into F. tularensis LVS by 
transconjugation from E. coli. 
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RNA Extraction. 
 RNA was isolated from Mueller Hinton broth cultures of F. tularensis LVS 
parental strain and FTL0552 mutant grown overnight to log phase (OD550 of 0.600).  
RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA).  The aqueous phase 
was used in the RNeasy clean-up protocol (Qiagen, Valencia, CA) with a 15 minute 
DNase digestion step (Qiagen, Valencia, CA) (9).  The concentration of the RNA was 
assessed at OD260 and OD280, and the integrity of the 23S and 16S rRNA was verified on 
a 0.7% agarose gel. 
 
RT-PCR analysis of FTL0552 and downstream genes.   
  Primers were designed for the second and fifth gene immediately downstream of 
FTL0552 (Table 1).  RT-PCR was performed using the One-Step RT-PCR kit (Qiagen, 
Valencia, CA).  Primers FTL0552-F and FTL0552-R (specific for FTL0552), primers 
lepB-F and lepB-R (specific for lepB), primers rnr-F and rnr-R (specific for rnr) and 
primers mutS-F and mutS-R (specific for the reference house keeping gene, mutS) were 
used to reverse transcribe and amplify the cDNA synthesized from RNA isolated from 
both the F. tularensis LVS parental strain and the FTL0552 mutant.  The products sizes 
are 352 bp for FTL0552, 288 bp for lepB, 314 bp for rnr and 304 bp for mutS.   The 
conditions for reverse transcription and amplification were 50ºC for 30 minutes and 95ºC 
for 15 minutes, followed by 30 cycles of 94ºC for one minute, 55ºC for 1 minute and 
68ºC for 1 minute, then a final elongation step of 72ºC for 10 minutes.  For each primer 
set, reactions lacking reverse transcriptase were performed to detect DNA contamination.  
PCR products were run on a 1.0% agarose gel. 
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RT-PCR analysis of F. tularensis LVS operon transcript. 
 Overlapping primers were developed to determine if FTL0552 and the four genes 
immediately downstream are transcribed as one contiguous transcript.  The four sets of 
primers, operon 1, operon 2, operon 3, and operon 4, were designed to produce 
overlapping PCR products ranging from 700-900 base pairs in size (Table 1).  RNA was 
extracted as previously described.  An additional DNase treatment was performed prior to 
reverse transcription by adding DNase to each RNA sample and heating for 10 minutes at 
37ºC.  The conditions for reverse transcription and amplification were 50ºC for 30 
minutes and 95ºC for 15 minutes, followed by 35 cycles of 94ºC for one minute, 55ºC for 
1 minute and 68ºC for 1 minute, then a final elongation step of 72ºC for 10 minutes.  For 
each primer set, reactions containing no RNA and no reverse transcriptase were 
performed to detect DNA contamination.  PCR products were run on a 0.7% agarose gel. 
  
Intracellular Survival Assay.   
The method for assessing intracellular growth of F. tularensis LVS in 
macrophages was performed with minor modifications of the method previously 
described by Golovliov et al. (34).  J774A.1 mouse macrophage cells suspended in 
DMEM media (Dulbeccos Modification of Eagles Medium (DMEM), 10% FBS, 
4.5g/mL glucose and L-glutamine)  were seeded into a 24 well tissue culture plate at a 
density of 6x104 cells/well and incubated overnight at 37ºC with 5% CO2.  F. tularensis 
LVS parental and FTL0552 mutant strain were suspended in DMEM, added to each well 
at an MOI of 100, and allowed to infect for 2 hr at 37ºC in 5% CO2.   Following infection, 
the cells were washed twice with PBS to remove extracellular bacteria.  Gentamicin 
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(50µg/ml) was added to the wells and the incubation was allowed to continue for 1 hr.  
Thereafter, the cells were washed once with PBS and media containing gentamicin 
(2µg/ml) was added to the wells.  At various time points (0, 24, 48 and 72 hrs) the cells 
were washed with PBS and lysed with 0.1% sodium deoxycholate.  Viable counts were 
performed by plating serial 10-fold dilutions of the lysates on supplemented GC agar 
plates and incubating at 37ºC (34).  All experiments were performed in triplicate.  The 
data are representative of three independent experiments.  Infection of peritoneal exudate 
cells (PECs) was performed with modifications of the method described by Twine et al. 
(89).  Peritoneal cells (PC) were collected from thioglycolate treated BALB/c mice, 
washed and resuspended in medium containing, 10% FBS, 50µM 2-mercaptoethanol, and 
L-glutamine.  PC cell suspensions were seeded into a 96 well tissue culture plate at a 
density of 1x105 cells/well and incubated overnight at 37ºC in 5% CO2.  F. tularensis 
LVS and FTL0552 mutant bacteria were added to each well at an MOI of 50 and allowed 
to infect for 1.5 hrs.  The cells were then washed twice with HBSS to remove 
extracellular bacteria.  Medium containing gentamicin (50µg/ml) was added to the wells 
and incubated for 1 hr.  Thereafter, the cells were washed once with HBSS and cultured 
in medium containing gentamicin (2µg/ml).  At various time points, (0, 12, 24 and 48 
hrs) the cells were washed with HBSS and lysed with 0.1% saponin.  Viable counts were 
performed by plating serial 10-fold dilutions of the lysates on supplemented GC agar 
plates and incubating at 37 ºC (32).  All experiments were performed in triplicate.    
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Fluorescence Microscopy.   
FTL0552 mutant was stained with PKH67 green fluorescent cell linker mini kit 
(Sigma St. Louis, MO) as per the manufacturers instructions.  LVS transformed with a 
GFP containing plasmid was used a control.  1x104 MH-S (murine alveolar macrophage 
cell line) cells in RPMI-1640 supplemented with 10% FBS (Invitrogen Inc, Carlsbad, 
CA) were seeded on a sterile Lab-Tek chamber slide (Nalge Nunc International, 
Rochester NY) and incubated for 12 hr at 370C.  The cells were infected with the labeled 
FTL0552 or the GFP-LVS at an MOI of 100 and incubated at 370C for 15, 30 and 45 
minutes.  Uninfected cells served as controls.  After each indicated time, the cells were 
washed twice with sterile PBS and fixed with 3% paraformaldehyde.  The MH-S cells 
were counterstained with PKH26 red fluorescence cell linker mini kit (Sigma St. Louis, 
MO) as per the manufacturers instructions.  The cells were washed, mounted with the 
coverslips and observed under a fluorescent microscope.  For confocal microscopy 0.5 
µM Z sectioning was performed on a confocal microscope (Carl Zeiss Laser Scanning 
System, Biocompare Inc., San Francisco, CA).  The slides were observed under a C-
Apochromat objective at 40x magnification with 1.2 W corrections and visualized in 
channel-1 at 500-550 IR and channel-2 at 565-615 IR.  The images were analyzed using 
LSM5 image browser software version 3,2,0,115 (Carl Ziess, Biocompare Inc., San 
Francisco, CA). 
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Magnesium Assay.   
 LVS parent strain and FTL0552 mutant cultures were grown at 37ºC in 5mL MH 
broth containing increasing concentrations of magnesium (0-500µM).  After 18-24 hours, 
the OD550 was measured to assess growth. 
 
pH Assay. 
 LVS parent strain and FTL0552 mutant cultures were grown at 37ºC in 5mL of 
MH broth at varying pH levels (6.5-4.0).  After 18-24 hours, the OD550 was measured to 
assess growth. 
 
Hydrogen Peroxide Killing Assay. 
 LVS wild type and FTL0552 mutant bacteria was cultured at 37ºC in MH broth to 
log phase (OD550 of 0.6) and diluted 1:100 in MH broth before mixing 50µl of each 
bacterial culture with 50µl of 30mM hydrogen peroxide in MH broth or with 50µl of MH 
broth alone (untreated control).  The mixture was incubated at 37ºC in a 96 well culture 
plate and samples were collected at times points 0, 5, 10, 20, and 30 minutes.  Serial 
dilutions of the samples at each time point were plated on GC agar plates to determine 
viable colony forming units. 
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Determination of FTL0552 mutant Polymyxin B Minimum Inhibitory 
Concentration (MIC). 
 LVS wild type and FTL0552 mutant bacterial cultures were incubated at 37ºC 
with agitation overnight in 5mL of MH broth supplemented with various concentrations 
(15.6µg/mL - 1000µg/mL) of polymyxin B.  OD550 measurements were taken at 18-24 
hours to determine the MIC.   
     
Mouse infection.   
Six to eight week-old BALB/c and C57BL/6 mice (Taconic, Germantown, NY) of 
either sex were housed in a specific pathogen free environment in the Animal Resource 
Facility at Albany Medical College and used for screening of the FTL0552 mutant.  A 
frozen aliquot of F. tularensis LVS or F. tularensis LVS FTL0552 mutant was thawed 
and diluted in sterile PBS.  Prior to intranasal (i.n.) inoculation, the mice were deeply 
anesthetized via intraperitoneal injection of a cocktail of Ketamine (20mg/ml) and 
Xylazine (1 mg/ml).  The mice (n=10 for each group) were infected i.n. with 1x104 or 
1x105 CFU of LVS or FTL0552 mutant in a volume of 20 µl PBS (10 µl per nare).  The 
mice were monitored closely for morbidity and mortality for a period of 21-30 days post-
infection and the median survival time (MST) was calculated for each group of mice.  
Mice that survived the initial infection dose of 1x105 CFU of FTL0552 mutant were 
challenged with 1x102 CFU of the virulent F. tularensis Schu S4 strain.  All mice that 
survived 1x104 CFU of FTL0552 mutant were boosted with 1x105 CFU of FTL0552 
mutant and challenged 30 days later with 1x102 CFU of Schu S4.  Actual numbers of 
bacteria were determined by plating the inoculum after primary infection and challenge.  
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All the Schu S4 challenge experiments were carried out in the ABSL-3 facility of the 
Albany Medical College following standard operating procedures.  All experiments 
conformed to the animal procedures approved by Institutional Animal Care and Use 
Committee guidelines 
A time course experiment was conducted to determine the kinetics of bacterial 
clearance.  BALB/c and C57BL/6 mice were infected i.n. with 5x103 CFU of either LVS 
or FTL0552 mutant.  A group of four mice each was sacrificed at days 1, 3, 5 and 7 post-
infection.  Lung, liver and spleen were collected aseptically for quantitation of bacterial 
burden and histology at the indicated times. 
 
Quantification of F. tularensis burden.   
Bacterial burdens were quantified in the lungs, livers and spleens of C57BL/6 and 
BALB/c mice.  The lungs from the infected mice were inflated with sterile PBS and 
collected aseptically in PBS containing a protease inhibitor cocktail (Roche Diagnostics, 
Indianapolis, IN).  Livers and spleens were also collected in a similar fashion.  The 
organs were subjected to mechanical homogenization using a Mini-BeadBeater-8 
(BioSpec Products Inc., Bartlesville, OK).  The tissue homogenates were spun briefly at 
1000 x g for 10 sec in a microcentrifuge to pellet the tissue debris.  Supernatants were 
diluted 10-fold in sterile PBS and 10 µl of each dilution were spotted onto chocolate agar 
plates in duplicate and incubated at 37°C for 2-3 days.  The number of colonies on the 
plates were counted and expressed as CFU/gram of tissue.  The remaining tissue 
homogenates were spun at 14000 × g for 20 min and the clarified supernatants were 
stored at -20°C and used for measurement of tissue cytokine levels. 
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Histopathology.   
The lungs, livers, and spleens from infected mice were excised at days 1, 3, 5 and 
7 post-infection and fixed with 10% neutral buffered formalin.  Lungs were inflated via 
instillation of PBS into the trachea prior to fixation.  Tissues were processed using 
standard histological procedures and 5 µm paraffin sections were stained with 
hematoxylin-eosin and examined by light microscopy. 
 
Cytokine measurement.   
Mouse Inflammation Cytometric Bead Array (CBA) Kits (BD Bioscience, San 
Diego, CA) were used for the simultaneous measurement of multiple cytokines in lung 
homogenates of BALB/c and C57BL/6 mice infected either with LVS or FTL0552 
mutant.  Data were acquired on a FACSArray (BD Immunocytometry Systems) and 
analyzed using CBA software version 1.1. 
 
Gene Microarray analysis.    
RNA was extracted from broth cultures grown to log phase using the Enzymatic 
Lysis and Proteinase K Digestion of Bacteria protocol from the RNAprotect Bacteria 
Reagent Handbook (Qiagen, Valencia, CA), followed by purification using the RNeasy 
Mini Kit Purification of Total RNA from Bacterial Lysate protocol (Qiagen, Valencia, 
CA).  cDNA was synthesized from 1µg of total RNA in a standard reverse transcription 
(RT) reaction using 5 µg of random hexamers (Amersham Biosciences, Piscataway, NJ) 
and Superscript III (Invitrogen). Amino allyl dUTPs were incorporated at this step (2.5 
mM dATP, 2.5 mM dCTP, 2.5 mM dGTP, 1 mM amino allyl dUTP, and 1.5 mM dTTP) 
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(Invitrogen).  cDNA was purified using Zymo DNA purification columns as specified by 
the manufacturer (Zymo Research Corp., Orange, CA), and samples were labeled with 
Cy5 (red) fluorophores and the reference was labeled with Cy3 (green) fluorophores 
(Amersham Biosciences).  Unincorporated fluorophores were quenched using 5µl of 4M 
hydroxylamine and incubated in the dark for 15 min.  The samples were then combined, 
and unincorporated dyes were removed using Zymo DNA purification columns.  For 
hybridization, cDNA was eluted in 19µl of Tris-EDTA buffer, and 2µl of 20mg/ml yeast 
tRNA (Invitrogen), 4.25 µl of 20× SSC, and 0.75µl of 10% sodium dodecyl sulfate were 
added to the probe.  Probes were denatured for 2 min at 99°C, spun at 17,900 × g, and 
cooled at room temperature before they were added to the arrays.  The samples and arrays 
were incubated at 60°C for ~14 h, and stringency washes were performed.  Briefly, the 
arrays were washed for 2 min each in a series of four washes with increasing stringency: 
(i) 2× SSC-0.03% sodium dodecyl sulfate, (ii) 2× SSC, (iii) 1× SSC, and (iv) 0.2× SSC.  
The microarrays were scanned and analyzed using a Gene Pix 4000A scanner and 
GENEPIX5.1 software (both from Axon Instruments, Redwood City, CA).  Normalized 
data were collected using the Stanford Microarray Database.  Spots were excluded from 
analysis due to obvious abnormalities, a regression correlation of <0.6, or a Cy3 net mean 
intensity of <100.  Only spots with at least 70% good data across the experiment were 
included for analysis.  The ratios of the red channels to green channels for each spot were 
expressed as log2 (red/green) and used for hierarchical clustering using the CLUSTER 
program.  Results were visualized using the TREEVIEW program.  Using data from all 
of the microarrays, significant differences between the wild-type and mutant were 
determined using the Significance Analysis for Microarrays (SAM) program, v. 1.21.  
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Using the two-class statistical analysis tool in the SAM program, a list of genes whose 
transcript levels were significantly increased or decreased between the two groups was 
calculated.  A calculated false discovery rate of <1% was used to assign significance, and 
a two-fold cutoff in the change in expression level was imposed. 
 
Silver Stain of SDS-PAGE gel. 
 F. tularensis LVS parent strain and FTL0552 were grown in MH broth cultures to 
log phase and spun down at 2500 rpm for 10 minutes to pellet the bacterial cells.  The 
supernatant was removed, filter-sterilized, and concentrated in a Centricon-Plus-20 
Centrifugal Filter Unit (Millipore Corporation, Billerica, MA).  Cell lysate and 
concentrated supernatant samples were prepared using the NuPAGE® Novex® Bis-Tris 
Gel protocol (Invitrogen, Carlsbad, CA).  Briefly, NuPAGE® LDS Sample Buffer (4x), 
NuPAGE® Reducing Agent (10x) and deionized water was added to each sample and 
heated for 10 minutes at 70ºC.  1x SDS Running Buffer was prepared using 20x 
NuPAGE® MES and deionized water.  10µg or 20µg of each sample was loaded on a 4-
12% NuPAGE® Novex® Bis-Tris Mini Gel (Invitrogen, Carlsbad, CA) and 
electrophoresis was performed according to manufacturers instructions.  The gel was 
fixed, washed, and stained according to manufacturers instructions using the Silver Stain 
Plus Kit (Bio-Rad Laboratories, Inc., Hercules, CA).      
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Statistical analyses.   
The survival results are expressed as Kaplan-Meier curves and P values were 
determined using a Log-Rank test.  All other results were expressed as mean ± SEM and 
comparisons between the groups were made using one-way ANOVA followed by 
Bonferronis correction, nonparametric Mann-Whitney test, or Students t-test.  
Differences between the experimental groups were considered significant at P< 0.05 
level. 
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Results 
 
Identification of the response-regulator gene.   
Dr. Jean Citron first identified a putative response-regulator in the F. tularensis 
subsp. tularensis Schu S4 genome by homology with a consensus PhoP amino acid 
sequence derived from alignment of the deduced peptide sequence from other Gram-
negative bacteria.  The FTT1557c locus from the Schu S4 genome sequence was 
identified and shown to have motifs consistent with response-regulator proteins, 
containing both a response-regulator receiver domain and a transcriptional regulatory 
protein domain.  Prior to publication of the F. tularensis LVS genome, Dr. Citron 
obtained the incomplete LVS genome sequence from Dr. Emilio Garcia from Lawrence 
Livermore National Laboratories.  Dr. Citron compiled a file aligning the overlapping 
LVS sequence contigs to begin searching against the database for possible homologs to 
FTT1557c and other possible virulence regulator genes.  It was with this alignment that 
she first identified potential genes in F. tularensis LVS sharing homology with the 
derived consensus PhoP sequence, as well as other genes associated with virulence 
regulation in gram negative bacteria, such as, rpoH (RNA polymerase sigma factor), and 
qseA (quorum sensing Escherichia coli regulator A).  Upon publication of the LVS 
genome sequence, she was able to confirm the presence of the coding sequence for a 
putative response-regulator protein (FTL0552 in LVS and FTT1557c in Schu S4) 
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identified by homology with a consensus PhoP amino acid sequence derived from 
alignment of the deduced peptide sequence from other Gram-negative bacteria.  The 
FTL0552 locus from the F. tularensis LVS genome sequence was identified and shown 
to have motifs consistent with response-regulator proteins, containing both a response-
regulator receiver domain and a transcriptional regulatory protein domain.  The locus is 
annotated as a two-component response-regulator, however, no sensor histidine kinase 
gene can be identified in the area immediately upstream or downstream of this gene (Fig. 
5).  Recent studies identified 16 genes in Francisella spp. involved in environmental 
signal transduction and only 4 appear to share homology with known TCS sensor 
histidine kinases or response-regulators.  None of the TCS genes appear to be paired in 
the genome as typical TCS operons in other Gram negative bacteria (63).  Although the 
locus was identified by homology with a PhoP consensus sequence, FTL0552 shares 
homology with other response-regulator proteins (63).  The gene arrangement of adjacent 
genes and the deduced amino acid sequence homology of this putative response-regulator 
gene is highly conserved between LVS and the virulent F. tularensis Schu S4 strain 
(locus FTT1557c shows only one conservative amino acid change in residues 21-228).   
The putative response-regulator gene (FTL0552) is the first gene in a series of five that 
appear to form a single operon with minimal intergenic spaces or in some cases 
overlapping genes (Fig. 5).  RT-PCR revealed that FTL0552 and the four downstream 
genes are transcribed as one complete transcript, suggesting that FTL0552 is the first 
gene of a five gene operon, transcribed from the same promoter (Fig. 6).  The amplicon 
using primers specific for the region from lepB to rnc, appears weak and is most likely 
due to the primer design and not the level of transcription for that region. 
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Figure 5.  Arrangement of FTL0552 and adjacent genes on the F. tularensis LVS 
genome (NC007880).  The genome locus tags are indicated as are the size of the genes in 
base pairs (top) and the intergenic space between genes (below).  The genes indicated are 
(as annotated on the genome sequence): Ψ; pseudogene; putative response-regulator, 
lepB; signal peptidase I, rnc; RNase III, truB; tRNA pseudouridine synthetase B, rnr; 
RNaseR, and oleI; delta9 acyl-lipid fatty acid desaturase.  The gene arrangement is 
suggestive of a five-gene operon transcribed from a promoter region upstream of 
FTL0552. 
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Figure 6.  mRNA of FTL0552 and the four downstream genes forms one complete 
transcript.  RT-PCR analysis of F. tularensis LVS, utilizing overlapping primers, was 
performed to determine whether FTL0552 is part of a five gene operon under the control 
of the same promoter.  Lane 2; amplicons using primers specific for the region from 
FTL0552 to lepB (operon 1-F and operon 1-R), lane 3; amplicons using primers specific 
for the region from lepB to rnc (operon 2-F and operon 2-R), lane 4; amplicons using 
primers specific for the region from rnc to truB (operon 3-F and operon 3-R), lane 5; 
amplicons using primers specific for the region from truB to rnr (operon 4-F and operon 
4-R).  PCR products were run on a 0.7% agarose gel. 
 response regulator 
900 bp 
 
700 bp 
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Mutation of F. tularensis LVS FTL0552. 
 F. tularensis LVS FTL0552 knockouts were confirmed by PCR using primers 
specific to FTL0552 and primers external to FTL0552 and the flanking region.  The PCR 
product from colonies obtained after one pass on media containing 5% sucrose revealed 
two bands, consistent with the size predicted for the LVS parent strain FTL0552 gene 
(2081bp) and the size predicted for the region of recombination (2349bp), indicating the 
second recombinant event had not occurred and that the shuttle vector was still present 
(Fig. 7A).  After three passes on media containing 5% sucrose, PCR of the same colonies 
revealed a single band at the size predicted for the recombinant region (2349bp), 
indicating a second recombinant event had occurred and that the shuttle vector had been 
lost.  PCR with the primers specific for a region within the FTL0552 gene (FTL0552-F 
and FTL0552-R, Table 1) revealed loss of the FTL0552 gene (Fig. 7B).  To confirm the 
recombination event occurred within the correct location within the chromosome, a third 
PCR was performed using primers specific for the region flanking the area of 
recombination  (FTL0552+1100-F and FTL0552+1100-R, Table 1).  The amplicon from 
this PCR reaction was the size predicted for recombination within the chromosome (3158 
bp) but differed from the F. tularensis LVS parent strain PCR product (2880 bp) (Fig. 
7C).  Primers specific for the kanR gene were also used in PCR reactions to confirm 
incorporation of the kanR gene within F. tularensis LVS.  Sequencing of the 3158 bp 
PCR product amplified from F. tularensis LVS FTL0552::kanR revealed that nucleotides 
26-645 of the FTL0552 gene (genome sequence 534341 to 534960) were deleted and 
replaced with the kanR gene.   RT-PCR using primers specific for FTL0552 was also 
performed to confirm loss of transcription of FTL0552 gene in F. tularensis LVS 
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FTL0552::kanR.  As expected, FTL0552 was not amplified from RNA isolated from F. 
tularensis LVS FTL0552::kanR but was amplified in the F. tularensis LVS parent strain 
(Fig. 8). 
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Figure 7.  Confirmation of FTL0552 knockout.  (A) PCR of colonies obtained after 
one passage on agar with 5% sucrose.  Primers are specific for the region of 
recombination to confirm replacement of FTL0552 with the kanR gene.  Lane 1; 
exACTGene mid range DNA ladder, Lane 2; amplicon from LVS parent strain, Lanes 3 
and 4; amplicons from potential FTL0552 mutants, Lanes 5 and 6; H2O controls.  (B)  
PCR of colonies after three passages on agar containing 5% sucrose.  Primers are specific 
for a region within the FTL0552 gene to confirm loss of FTL0552.  Lane 1; exACTGene 
mid range DNA ladder, Lane 2; amplicon from LVS parent strain, Lane 3; amplicon from  
A B
C 
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Figure 7 (Continued). 
potential FTL0552 mutant, Lane 4; H2O control.  (C) PCR of colonies after three  
passages on agar containing 5% sucrose.  Primers are specific for the region flanking the 
region of recombination to confirm incorporation within the chromosome.  Lane 1; 
Lambda BstE II DNA digest, Lane 2; amplicon from LVS parent strain, Lane 3; amplicon 
from potential FTL0552 mutant, Lane 4; H2O control.       
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Figure 8.  Deletion of FTL0552 gene does not effect transcription of downstream 
genes in the FTL0552 mutant.  RT-PCR analysis of F. tularensis LVS FTL0552 and 
adjacent genes was performed to confirm loss of FTL0552 transcription in the F. 
tularensis LVS FTL0552 mutant and to determine the effects on downstream genes.  
Lanes 1 and 2; amplicons using FTL0552 specific primers FTL0552-F and FTL0552-R, 
lanes 3 and 4; amplicons using mutS  (house keeping gene) specific primers mutS-F and 
mutS-R, lanes 5 and 6; amplicons using lepB specific primers lepB-F and lepB-R, lanes 7 
and 8; amplicons using rnr specific primers rnr-F and rnr-R.  F. tularensis LVS RNA was 
used for the reactions in lanes 1, 3, 5, 7 and 13.  FTL0552 mutant RNA was used for the 
reaction in lanes 2, 4, 6, 8 and 14.  Lanes 9-12 are water controls and lanes 13 and 14 are 
no reverse transcription (RT) controls.  All PCR products are run on a 1.0% agarose gel. 
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FTL0552 mutation appears to have little effect on downstream genes.   
RT-PCR analysis, using overlapping primers was performed on RNA isolated 
from F. tularensis LVS and F. tularensis LVS FTL0552 mutant using primers specific 
for FTL0552, lepB and rnr (Table 1).  The two genes, lepB and rnr, were selected to 
determine the effects of knocking out FTL0552 on transcription of downstream genes 
within the potential operon (Fig. 8). The results confirmed that FTL0552 was not 
transcribed in the mutant strain, while the two downstream genes examined were 
transcribed at levels similar to those seen in LVS (Fig. 8).  Therefore, the phenotype seen 
in the FTL0552 knockout mutant is not a result of polar effects but is directly attributed 
to the mutation in FTL0552 and genes outside the putative operon that are regulated by 
FTL0552.    
 
FTL0552 mutant is unable to replicate in mouse macrophages.   
A growth comparison between the LVS parental strain and the FTL0552 mutant 
was performed to assess the effects of knocking out the FTL0552 gene on the bacterias 
ability to grow in an acellular environment.  Isolated colonies of F. tularensis LVS were 
visible on supplemented GC agar plates in 24 hours.  In contrast, isolated colonies from 
the FTL0552 mutant were visible in 38-42 hours.  Overnight broth cultures were 
incubated at 37ºC with aeration for a period of 4 days and OD550 readings were measured 
at several time points during the course of growth.  Growth of the FTL0552 mutant 
reached the same cell density as the parental strain of LVS, however, at a slightly slower 
rate (Fig. 9).  The mutant reached stationary phase of growth about 6-8 hrs after the 
parental strain LVS.   
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Figure 9. FTL0552 mutant exhibits a growth defect under acellular growth 
conditions.  The effect of FTL0552 gene deletion on growth under acellular conditions 
was assessed by growing the FTL0552 mutant and wild type F. tularensis LVS in 
Mueller Hinton broth.  Aliquots were removed at the times indicated and the optical 
density was measured at 550nm (OD550).   
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 The ability of the mutant to invade and replicate within mouse macrophages was 
assessed using J774A.1 cells and mouse peritoneal macrophages.  The cells were infected 
with the parental strain LVS or FTL0552 mutant LVS at an MOI of 100 for J774A.1 cells 
and an MOI of 50 for peritoneal cells for 2 hrs and 1.5 hrs, respectively.  At the indicated 
time points, viable counts were performed by lysing the cells and incubating serial 
dilutions of the sample suspensions on GC agar plates.  Over a period of 72 hrs, F. 
tularensis LVS was able to invade and replicate within J774A.1 cells and bacterial 
numbers increased approximately 50-fold (Fig. 10A).  However, no viable bacteria were   
recovered from J774A.1 cells infected with F. tularensis LVS FTL0552 mutant (Fig. 
10A).  Viable bacteria from PCs infected with the FTL0552 mutant were recovered but 
the numbers were significantly less than the parental strain (Fig. 10B).  Over a period of 
48 hrs, the mutant bacterial numbers increased <20-fold, compared to the parental strain 
bacterial numbers which increased >700-fold.  An important factor contributing to the 
virulence and dissemination of F. tularensis within a host is its ability to invade and 
replicate within host macrophages.  Mutation in FTL0552 appears to significantly alter 
the bacteriums ability to invade and replicate within mouse macrophage cells.   
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Figure 10. Intracellular Survival Assay.  (A) Macrophage invasion assay of FTL0552 
mutant and F. tularensis LVS.  Murine macrophage J774A.1 cells were infected with 
FTL0552 mutant and F. tularensis LVS at an MOI of 100.  Bacteria were allowed to 
adhere to cells for two hours and then treated with 50 µg/ml gentamicin to kill the 
extracellular bacteria.  At the indicated time points, cells were lysed, serially diluted and 
plated on GC agar plates to determine colony forming units.  (B) Similar experiments 
were conducted using thioglycolate elicited peritoneal macrophages from BALB/c mice 
infected at an MOI of 50 for 1.5 hours.  The results are expressed as CFU/ml and 
represent means ± standard errors of the means of the colony forming unit counts (n = 3  
per time point).  *, P < 0.001; **, P < 0.05 (using the Students T-Test).   
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FTL0552 mutant is deficient for invasion in MH-S alveolar macrophages.   
The cell culture invasion assay with the J774 cells and the elicited peritoneal 
macrophages has shown that the FTL0552 mutant is incapable of intracellular survival.  
We investigated further if this phenotype is due to the inability of FTL0552 to invade the 
macrophages.  After 30 min of incubation with the labeled bacteria, we observed that 
majority of the MH-S cells infected with GFP-LVS harbored 2-10 bacteria per cell.  On 
the contrary, cells infected with FTL0552 mutant contained very few bacteria (1-3 
bacteria per cell) (Fig. 11).  The results demonstrate that FTL0552 mutant is deficient for 
invasion in the macrophages.  Confocal microscopy confirmed that bacteria stained green 
were localized inside the cells whereas, bacteria that took the counter stain and appeared 
yellow when the images were merged together, were localized on the surface of the 
macrophages (Fig. 11 Insets). 
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Figure 11.  Macrophage invasion assay using fluorescently labeled F. tularensis 
FTL0552 mutant and GFP-LVS.  Blue arrows indicate the bacteria stained green are 
located inside the macrophages, where as, white arrows indicate bacteria stained yellow 
are present on the surface of the cell. The macrophages were counterstained with PKH26 
red fluorescence dye (Sigma St Louis, MO).  Insets: Confocal images confirming the 
localization of the bacteria within the cells. 
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FTL0552 mutant is not affected by increasing levels of Magnesium, or acidic pH.  
 In Salmonella spp., the expression of several genes essential to survival in Mg2+-
limiting environments is governed by the PhoP/PhoQ system.  Micromolar 
concentrations of Mg2+ has been shown to activate transcription of at least 18 PhoP 
activated genes, which are repressed in macromolar concentrations of Mg2+ (79).  In 
addition, other environmental conditions have been shown to modulate the expression of 
other PhoP regulated genes essential to the survival of the bacteria in conditions such as 
low pH or in the presence of hydrogen peroxide (79, 88).  To assess whether FTL0552 
responds to the same environmental stimuli as PhoP in other gram negative bacteria, I 
compared the growth of F. tularensis LVS parent strain to the FTL0552 mutant in media 
containing increasing concentrations of Mg2+ (Fig. 12).  Surprisingly, the mutant grew 
equally well in lower levels of Mg2+, compared to the parental strain.  In addition, as the 
Mg2+ concentration increased, growth of the parental strain decreased, whereas growth of 
the FTL0552 mutant remained unaffected.  The results suggest that FTL0552 is not 
involved in Mg2+ transport.   The growth of F. tularensis LVS parent strain and the 
FTL0552 mutant in media of varying pH levels was then compared (Fig. 13).  Again, the 
FTL0552 mutant did not respond to acidic pH levels as expected for a PhoP mutant.  The 
FTL0552 mutant grew equally as well as, if not slightly better than, the parental strain in 
an acidic environment.  The results suggest that low pH alone is not an environmental 
signal activating FTl0552 or governing the expression of FTL0552 regulated genes 
essential to the survival of the bacteria in an acidic environment.  Since PhoP has been 
shown to play a role in hydrogen peroxide resistance in some bacteria, a comparison of 
FTL0552 mutant sensitivity to hydrogen peroxide and F. tularensis LVS parental strain 
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was performed (Fig. 14).  There was no apparent difference observed between the 
hydrogen peroxide sensitivity of the FTL0552 mutant as compared to the parental strain.  
This alone does not indicate that FTL0552 does not play a role in hydrogen peroxide 
resistance.  Salmonella PhoP knockouts are susceptible to hydrogen peroxide killing 
when grown in low Mg2+.  Previous studies suggest that a functional phoP gene is 
necessary for normal levels of rpoS during growth in low Mg2+.  RpoS controls the 
antioxidant enzyme exonuclease IIII, responsible for hydrogen peroxide resistance.  
Inactivation of RpoS, renders Salmonella hypersensitive to hydrogen peroxide (88).  The 
rpoS gene is not found in F. tularensis LVS or the Schu S4 strain.  Perhaps there could be 
a similar connection between phoP and another rpoS-like gene in F. tularensis LVS.  
However, FTL0552 does not appear to function or respond to the environmental signals 
in the same manner as PhoP of other Gram negative bacteria.  This suggests that, 
although FTL0552 was identified by homology to a PhoP consensus amino acid 
sequence, it does not display the same phenotypic properties of PhoP in other bacteria.   
Recent studies identified and characterized the same gene (FTT1557c, 
FNU0663.2) as an orphan response-regulator in F. tularensis subsp. novicida.  The locus 
was identified by homology to the Salmonella PmrA response-regulator.  The Salmonella 
TCS, PmrAB, regulates resistance to the antimicrobial peptide (AMP) polymyxin B.  A 
F. tularensis subsp. novicida pmrA mutant was 32-fold more susceptible to polymyxin B 
than the parental strain (63).  The F. tularensis LVS FTL0552 mutant was initially 
selected on media containing 100µg/mL of polymyxin B, suggesting that FTL0552 is not 
essential for resistance to polymyxin B in F. tularensis LVS.  Polymyxin B MIC studies 
revealed that there is no difference between the polymyxin B susceptibility of the 
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FTL0552 mutant and the F. tularensis LVS parental strain.  Both strains were resistant to 
polymyxin B up to 1000µg/mL.  Therefore, FTL0552 does not appear to display the same 
phenotypic properties as PmrA of other Gram negative bacteria.       
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Figure 12.  F. tularensis LVS FTL0552 mutant response to increasing levels of 
magnesium.  LVS parent strain and FTL0552 mutant were grown in MH broth 
containing increasing levels of magnesium.  The optical density was measured to assess 
growth.  
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Figure 13.  F. tularensis FTL0552 mutant response to acidic pH.  LVS parent strain 
and FTL0552 mutant were grown in MH broth of decreasing pH levels.  The optical 
density was measured to assess growth. 
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Hydrogen peroxide Killing Assay
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Figure 14.  F. tularensis LVS FTL0552 mutant response to hydrogen peroxide.  LVS 
parental strain and FLT0552 mutant bacterial cultures were either treated with hydrogen 
peroxide or left untreated and incubated for 30 minutes.  Serial dilutions of the samples at 
each time point were plated on GC agar plates to determine viable colony forming units. 
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FTL0552 mutant is attenuated for virulence in mice.   
We screened the FTL0552 mutant in BALB/c and C57BL/6 mice to assess the 
effect of the gene deletion on virulence.  It was observed that all mice (n=10) of both 
strains infected with 1x104 or 1x105 CFU of F. tularensis LVS succumbed by days 17-19 
post infection.  In contrast, all BALB/c and C57BL/6 mice survived similar doses of 
FTL0552 mutant to at least day 21 post-infection (Fig. 15A and 15B).  All mice that 
survived the primary infective dose of 1x105 of FTL0552 mutant were challenged with 
1x102 CFU of Schu S4 strain.  It was observed that C57BL/6 mice had a significantly 
extended MST of 9 days as compared to 6.5 days for the naive challenged mice.  In the 
BALB/c mice challenged with Schu S4, the first death was recorded at day 12 post-
challenge and 30% (3/10) of the mice survived the challenge dose out to at least 45 days 
post-challenge when the experiment was terminated (Fig. 15C).  The other groups of 
mice that survived initial infection with 1x104 CFU of FTL0552 were subsequently 
boosted with 1x105 CFU of FTL0552 mutant and challenged with 1x102 CFU of Schu 
S4.  Although the MST for C57BL/6 mice treated in this manner was not altered 
following challenge, 40% of the BALB/c mice survived until day 21 post-challenge and 
the others had a significant delay in time to death (Fig. 15D).  Thus, these results show 
that the FTL0552 mutant is not only highly attenuated for virulence in mice, but also 
retains its antigenic potential and provides partial protection against virulent Schu S4 
challenge. 
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Figure 15.  FTL0552 mutant is attenuated for virulence in mice and provides partial 
protection against lethal Schu S4 challenge.  Survival of BALB/c (A) (n = 10) and 
C57BL/6 (B) (n = 10) mice infected intranasally with 1 x 104 or 1x105 CFU of FTL0552 
mutant or F. tularensis LVS.   
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Figure 15 (Continued). (C). Mice surviving 1x105 CFU of FTL0552 mutant (n=10) 
were challenged with 1x102 CFU of Schu S4.  (D) Mice surviving 1x104 CFU of 
FTL0552 mutant (n=10) were boosted with 1x105 CFU of FTL0552 mutant and 
challenged 30 days later with 1x102 CFU of F. tularensis Schu S4 strain.  Untreated mice 
were kept as controls.  Results are expressed as Kaplan-Meier curves and P values 
determined using a Log-Rank test.   
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FTL0552 mutant exhibits markedly reduced systemic dissemination and is cleared 
rapidly.   
We further investigated the kinetics of clearance of the FTL0552 mutant in mice.  
C57BL/6 and BALB/c mice were infected i.n. with 5x103 CFU of either FTL0552 mutant 
or LVS.  The mice were sacrificed at the indicated times and bacterial numbers were 
quantitated in the lung, liver and spleen.  An identical pattern of bacterial kinetics was 
observed in both BALB/c and C57BL/6 mice.  At days 1, 3 and 5 post-infection, bacterial 
numbers were significantly lower in the lungs of FTL0552 mutant-infected mice 
compared to LVS infected mice, and at day 7 post-infection, bacteria were completely 
eliminated from the lungs of FTL0552 mutant-infected mice (Fig. 16A).  No significant 
differences were observed in bacterial numbers in LVS or FTL0552 mutant infected mice 
in the liver, at day 3 post-infection, but at subsequent time points no bacteria were 
detected in FTL0552 mutant infected mice.  Significantly lower numbers of FTL0552 
mutant bacteria disseminated to the spleen as compared to the liver and no detectable 
bacteria were seen day 5 and 7 post-infection (Fig. 16B).  These results corroborate 
attenuated virulence of FTL0552 mutant observed in mice and suggest that the 
attenuation of FTL0552 mutant may be due to the rapid clearance and significantly 
diminished dissemination. 
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Figure 16.  FTL0552 mutant is rapidly cleared by BALB/c and C57BL/6 mice.  (A) 
BALB/c and C57BL/6 mice were inoculated intranasally with 5 x 103 CFU of FTL0552 
mutant or F. tularensis LVS.  Four mice were killed at each indicated time point, and 
homogenates of the lungs were plated for the determination of bacterial burden.  (B) 
Numbers of bacteria were quantified in the liver and spleen of the mice at day 3 post-
infection.  Results represent the means ± standard errors of CFU counts (n = 4 per time 
point). **, P < 0.01; ***, P < 0.001 (using the nonparametric Mann-Whitney test). 
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Infection with FTL0552 mutant induces less severe histological lesions.   
Extensive damage to vital organs is believed to be the primary cause of death 
from F. tularensis infection.  We observed that the FTL0552 mutant is rapidly cleared; 
we further evaluated tissue sections from LVS and FTL0552 mutant infected mice to 
compare the degree of damage caused to the tissues by the two bacterial strains.  Lesions 
in the lungs, livers and spleens of FTL0552 mutant and LVS infected mice appeared as 
early as 3 days post-infection and subsequently became more extensive by days 5 and 7 
post-infection (Fig. 17A).  Lesions in the lungs of LVS infected mice consisted mostly of 
multifocal bronchopneumonia and extensive lymphocytic to neutrophilic peribronchial 
and perivascular inflammation.  However, these lesions were less severe and localized to 
very discrete areas in the lungs of FTL0552 mutant infected mice (Fig. 17A).  Livers 
from LVS infected mice showed numerous multifocal neutrophilic to lymphocytic 
granulomas.  These granulomas became larger as the infection progressed.  On the 
contrary, few and very small granulomas were observed in the FTL0552 mutant infected 
mice (Fig. 17B).  Lesions in the spleen consisted of multifocal to coalescing areas of 
neutrophilic infiltration in the red pulp, enlargement of the marginal zones, and extensive 
proliferative responses in the germinal centers.  However, the splenic tissue in FTL0552 
mutant-infected mice appeared to be normal and no inflammatory changes were observed 
(Fig. 17C).  The results indicate that although the FTL0552 mutant is rapidly cleared 
from the tissues, it still induces a degree of inflammation and development of mild 
pathological lesions in the lungs and liver. 
 
 
 63
 
 
Figure 17.  Mice infected with FTL0552 mutant exhibit markedly less severe 
histopathological lesions.  Histopathological changes in the H&E stained sections of 
lungs (A), liver (B), and spleen (C) of BALB/c and C57BL/6 mice (n=4) were evaluated 
at day 5 after intranasal inoculation with 5x103 CFU of FTL0552 mutant or F. tularensis 
LVS.  Lung, liver, and spleen sections of sham-inoculated mice served as a control. 
(Magnification x 40). Arrows indicate granulomas that were observed to be smaller in 
mice infected with the FTL0552 mutant than those infected with LVS. 
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Mice infected with FTL0552 mutant produce lower levels of inflammatory 
cytokines. 
Unregulated production of cytokines in response to F. tularensis infection has 
been shown to be responsible for the severe histopathological lesions observed in the 
lungs, livers and spleens of infected mice.  We determined the levels of inflammatory 
cytokines such as interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), 
interleukin-6 (IL-6), monocyte chemoattractant protein (MCP-1) and interleukin 12 (IL-
12)  in the lung homogenates of C57BL/6 and BALB/c mice infected either with LVS or 
the FTL0552 mutant.  LVS infected mice had significantly elevated levels of all 
cytokines except IL-12 at days 5 and 7 post-infection (Fig. 18).  The levels of IL-6 and 
IFN-γ in FTL0552 mutant infected mice were below detection levels whereas elevated 
levels of IL-12 were seen at day 7 post-infection.  The results suggest that lowered 
cytokine production results in less severe pathology in the lungs of FTL0552 mutant 
infected mice. 
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Figure 18.  FTL0552 mutant exhibits lower levels of proinflammatory cytokines.  
Following intranasal inoculation of BALB/c and C57BL/6 mice with 5x103 CFU of 
FTL0552 mutant or F. tularensis LVS, lung homogenates were prepared, and levels of 
proinflammatory cytokine levels were measured using Cytometric Bead Array (BD 
Pharmingen, San Diego, CA).  Results represent the means ± standard errors of the 
means of the cytokine concentrations (n = 4 mice per time point). *, P < 0.05; **, P < 
0.01; ***, P < 0.001 (by one-way ANOVA followed by Bonferroni's correction). 
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FTL0552 regulates genes essential for intracellular survival and virulence.   
  Gene microarray analysis revealed 148 genes regulated by FTL0552 (Table 2).  
The genes are identified by a 4-fold or greater difference between F. tularensis LVS 
parent strain and FTL0552 mutant.  The majority (75%) of the genes regulated are down 
regulated in the FTL0552 mutant, indicating they are FTL0552 activated genes.  Among 
the genes down regulated by the mutant, are the intracellular growth loci (iglA, iglB, iglC 
and iglD).  These genes are located in the FPI and have been shown to be essential for 
intracellular survival (34, 54, 58, 65).  Other down regulated genes include a macrophage 
infectivity potentiator fragment, the gene encoding a type IV pili fiber building block 
protein, ampC, fopA, and, interestingly, the superoxide dismutase gene, sodB.  The type 
IV pili fiber building block protein is involved in bacterial attachment and invasion of 
host cells.  Citrobacter freundii AmpC is a cytoplasmic membrane protein gene required 
for induction of ß-lactamase and was recently identified as a permease required for 
recycling of murein tripeptide and uptake of anhydro-muropeptides, which are produced 
by turnover of the cell wall during logarithmic growth of E. coli K-12 (13).  FopA is an 
outer membrane protein specific to F. tularensis and is used as the target gene to rapidly 
detect and distinguish F. tularensis from Francisella philomiragia and other bacteria by 
LightCycler (LC) PCR (30) .  The sodB gene in F. tularensis LVS encodes a functional 
FeSOD protein essential for bacterial survival under conditions of oxidative stress.  A 
sodB mutant was attenuated for virulence in mice, indicating that FeSOD plays a role in 
virulence of F. tularensis LVS (6).  The genes that are up regulated in the FTL0552 
mutant include several hypothetical proteins, and pseudogenes, two transposases, and, 
interestingly, the gene encoding a type IV pili nucleotide-binding protein, pilT.           
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Table 2.  Genes regulated by FTL0552. 
Fold Change adj.P.Val LVS loci Gene Product 
Genes down regulated in FTL0552 mutant 
-25.05928019 0.00233705 FTL_0236 rplC 50S ribosomal protein L3 
-22.19311691 0.00597319 FTL_1789 gltA citrate synthase 
-19.35758199 0.00468233 FTL_0254 rpmD 50S ribosomal protein L30 
-18.02126118 0.00710756 FTL_1751 tufA 
elongation factor Tu (EF-
Tu) 
-17.77871998 0.00275065 FTL_0253 rpsE 30S ribosomal protein S5 
-17.33021775 0.00816132 FTL_1452 rpmA 
50S ribosomal          
protein L27 
-17.19672181 0.01262576 FTL_1744 rpoB 
DNA-directed RNA 
polymerase beta chain 
-16.36824612 0.01503285 FTL_1158; FTL_0112 iglB 
intracellular growth locus, 
subunit B 
-16.04281684 0.01262576 FTL_0249 rpsN 30S ribosomal protein S14 
-15.70008434 0.01625823 FTL_1553 sucC 
Succinyl-CoA synthetase 
beta chain 
-15.6848517 0.00496561 FTL_1138 acpP acyl carrier protein 
-15.5530817 0.02435709 FTL_1180 ptsN 
PEP-dependent sugar 
phosphotransferase 
system (PTS) family 
protein 
-15.26151237 0.00597319 FTL_0250 rpsH 30S ribosomal protein S8 
-15.17791631 0.01259213 FTL_0456 rpsU1 30S ribosomal protein S21 
-15.02396164 0.00496561 FTL_0255 rplO 50S ribosomal protein L15 
-14.7544992 0.00861015 FTL_0104   
hypothetical membrane 
protein 
-14.14970215 0.02435709 FTL_1786 sdhA 
succinate dehydrogenase, 
catalytic and 
NAD/flavoprotein subunit 
-13.98444357 0.00387005 FTL_0234 fusA elongation factor G (EF-G) 
-13.95892199 0.01151088 FTL_0248 rplE 50S ribosomal protein L5 
-13.82131408 0.01118009 FTL_1405 rpmI 50S ribosomal protein L35 
-13.72452491 0.00928887 FTL_0251 rplF 50S ribosomal protein L6 
-13.62834175 0.01259213 FTL_0247 rplX 50S ribosomal protein L24 
-13.22678364 0.01831857 FTL_1159; FTL_0113 iglC 
intracellular growth locus, 
subunit C 
-12.67540688 0.01860968 FTL_1404 rplT 50S ribosomal protein L20 
-12.66500492 0.00721755 FTL_0252 rplR 50S ribosomal protein L18 
-12.41193477 0.0176315 FTL_0457 cspC cold shock protein 
-12.34048842 0.01118009 FTL_0243 rplP 50S ribosomal protein L16 
-11.89849425 0.00496561 FTL_0242 rpsC 30S ribosomal protein S3 
-11.52757836 0.02475487 FTL_1790 ampG 
major facilitator 
superfamily (MFS) 
tranport protein 
-11.33508028 0.01262576 FTL_1328 fopA 
outer membrane 
associated protein 
-11.17326652 0.01694981 FTL_1800 atpE ATP synthase C chain 
-11.16020392 0.00861015 
57 base overlap with 
FTL_1024 
overlaps 
rpsF 
overlaps 30S ribosomal 
protein S6 
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Table 2  (Continued). 
-10.76138971 0.01118009 FTL_1787 sdhD 
succinate dehydrogenase 
hydrophobic membrane 
anchor protein 
-10.75579449 0.01262576 FTL_1746 rplJ 50S ribosomal protein L10 
-10.53371666 0.01262576 FTL_1797 atpA ATP synthase alpha chain 
-10.43829441 0.02430586 FTL_1309 accD 
Acetyl-CoA carboxylase 
beta subunit 
-10.11923752 0.01982448 FTL_1792   
Glutaredoxin-related 
protein 
-10.11045205 0.03355773 FTL_1361 cspA cold shock protein 
-9.979771948 0.01625823 FTL_1479 pepA cytosol aminopeptidase 
-9.899502498 0.02915752 FTL_1748 rplK 50S ribosomal protein L11 
-9.748119357 0.01262576 FTL_1736 trmD 
tRNA (Guanine-N(1)-)-
methyltransferase 
-9.676818132 0.01625823 FTL_1591 accC 
Acetyl-CoA carboxylase, 
biotin carboxylase subunit 
-9.570639159 0.01831857 FTL_1791 sodB superoxide dismutase [Fe] 
-9.567494795 0.0130139 FTL_1026 rplI 50S ribosomal protein L9 
-9.535239754 0.01118009 FTL_1097   
macrophage infectivity 
potentiator, fragment 
-9.504769551 0.04137074 FTL_1843 gatC 
Glu-tRNAGln 
amidotransferase C 
subunit 
-9.348565178 0.00948832 FTL_0421 lpnA 
conserved hypothetical 
lipoprotein 
-9.309757306 0.0111118 FTL_0246 rplN 50S ribosomal protein L14 
-9.183991197 0.00948832 FTL_1735 rplS 50S ribosomal protein L19 
-9.130656462 0.02475487 FTL_1745 rplL 
50S ribosomal protein 
L7/L12 
-9.109343253 0.03973755 FTL_1749 nusG 
transcription 
antitermination protein 
nusG 
-8.97743477 0.01625823 FTL_1442 fabI 
Enoyl-[acyl-carrier-
protein] reductase 
(NADH) 
-8.931173932 0.01262576 FTL_1746 rplJ 50S ribosomal protein L10 
-8.860087763 0.01625823 FTL_1802   
hypothetical membrane 
protein 
-8.79275415 0.01625823 FTL_1783 sucB 
dihydrolipoamide 
succinyltransferase 
component of 2-
oxoglutarate 
dehydrogenase complex 
-8.411502096 0.01118009 FTL_0259 rpsK 30S ribosomal protein S11 
-8.2600092 0.01262576 FTL_1914   
conserved membrane 
protein 
-8.120925628 0.0448537 FTL_1747 rplA 50S ribosomal protein L1 
-7.98099707 0.01262576 FTL_1866 pcm 
Protein-L-isoaspartate O-
methyltransferase 
-7.975037811 0.0130139 FTL_0224 rpsB 30S ribosomal protein S2 
-7.953326091 0.00948832 FTL_1747 rplA 50S ribosomal protein L1 
-7.906516041 0.01942492 FTL_1800 atpE ATP synthase C chain 
-7.901501728 0.02657508 FTL_1236 infA 
translation initiation factor 
IF 
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Table 2  (Continued). 
-7.834059565 0.03192562 FTL_0449   hypothetical protein 
-7.76975055 0.00948832 FTL_0240 rpsS 30S ribosomal protein S19 
-7.723022596 0.02430586 FTL_1899 glnA glutamine synthetase 
-7.605369341 0.01625823 FTL_1160; FTL_0114 iglD 
intracellular growth locus, 
subunit D 
-7.523342004 0.01625823 FTL_1906 lpxC 
UDP-3-O-[3-
hydroxymyristoyl] N-
acetylglucosamine 
deacetylase 
-7.463597743 0.01587326 FTL_1808 rbfA Ribosome-binding factor A 
-7.425803224 0.0130139 FTL_1744 rpoB 
DNA-directed RNA 
polymerase beta chain 
-7.324906566 0.02779293 FTL_0522 rpmB 50S ribosomal protein L28 
-7.316623559 0.03355773 FTL_1794 atpC 
ATP synthase epsilon 
chain 
-7.106487115 0.02126889 FTL_0457 cspC cold shock protein 
-7.101383652 0.02915752 FTL_0225 tsf 
protein chain elongation 
factor EF-Ts 
-7.0326146 0.01880227 FTL_1161; FTL_0115   
conserved hypothetical 
protein 
-6.886330976 0.01474031 FTL_1785 sdhB 
succinate dehydrogenase 
iron-sulfur protein 
-6.814183939 0.02915752 FTL_1908 ftsA cell division protein FtsA 
-6.788131408 0.01569351 FTL_0232 rpsL 30S ribosomal protein S12 
-6.667272265 0.01262576 FTL_1392 deaD 
Cold-shock DEAD-box 
protein A 
-6.654382249 0.04137074 FTL_0552   
Two-component response 
regulator 
-6.582903729 0.02587972 FTL_1866 pcm 
Protein-L-isoaspartate O-
methyltransferase 
-6.390042955 0.02435709 FTL_1157; FTL_0111 iglA 
intracellular growth locus, 
subunit A 
-6.38412801 0.02475487 FTL_1364   
conserved hypothetical 
protein 
-6.382618562 0.04208055 FTL_1538 rpsO 30S ribosomal protein S15 
-6.356697689 0.03184661 FTL_1912 rpsA 30S ribosomal protein S1 
-6.315994198 0.01860968 FTL_0248 rplE 50S ribosomal protein L5 
-6.252961264 0.03500214 FTL_1400   
conserved hypothetical 
protein 
-6.233222608 0.01587326 FTL_1809 infB 
translation initiation factor 
IF-2 
-6.178737226 0.01810894 FTL_0262 rplQ 50S ribosomal protein L17 
-6.154009595 0.01625823 FTL_0175 rpmH 50S ribosomal protein L34 
-6.122084398 0.02915752 FTL_0166 usp universal stress protein 
-5.973209935 0.01587326 FTL_1461 deoD 
purine nucleoside 
phosphorylase 
-5.957196557 0.01587326 FTL_1799 atpF ATP synthase B chain 
-5.94144208 0.04208055 FTL_1811   
conserved hypothetical 
protein 
 
 
 
 
 
 70
Table 2  (Continued). 
-5.90717608 0.03500214 FTL_1785 sdhB 
succinate dehydrogenase 
iron-sulfur protein 
-5.836772303 0.02330711 FTL_1239 ffh 
signal recognition particle 
protein, Ffh 
-5.818402609 0.02891333 FTL_0252 rplR 50S ribosomal protein L18 
-5.71724013 0.03500214 FTL_1788 sdhC 
succinate dehydrogenase, 
cytochrome b556 
-5.620673623 0.02915752 FTL_1737 rimM 
16S rRNA processing 
protein rimM 
-5.612959849 0.03500214 FTL_1137 fabF 
3-oxoacyl-[acyl-carrier-
protein] synthase II 
-5.578672881 0.02700348 FTL_0392   
Type IV pili fiber building 
block protein 
-5.496727729 0.01729659 FTL_1789 gltA citrate synthase 
-5.456963006 0.02246866 FTL_1795 atpD ATP synthase beta chain 
-5.384322677 0.0448537 FTL_0070 rpsT 30S ribosomal protein S20 
-5.320586462 0.02435709 FTL_0260 rpsD 30S ribosomal protein S4 
-5.268390745 0.02988088 FTL_1453 rplU 50S ribosomal protein L21 
-5.235104687 0.02587972 FTL_1892; FTL_1317   hypothetical protein 
-5.192961998 0.02444671 FTL_1309 accD 
Acetyl-CoA carboxylase 
beta subunit 
-5.178980027 0.03184661 FTL_1738 rpsP 30S ribosomal protein S16 
-4.941337444 0.04390467 FTL_1504 katG Peroxidase/catalase 
-4.761407043 0.03905373 FTL_1143 rmpF 50S ribosomal protein L32 
-4.507271922 0.03754453 FTL_1780 tpiA 
triosephosphate 
isomerase 
Genes down regulated in FTL0552 mutant 
4.657900941 0.0476291 FTL_0010 glpe 
thiosulfate 
sulfurtransferase 
4.758190213 0.04862308 FTL_0864   SIS domain protein 
4.903062161 0.04424048 FTL_0035   hypothetical protein 
5.887486797 0.02330711 FTL_1373   hypothetical protein 
5.94921963 0.03500214 
intergenic between 
FTL_1368 and FTL_1369   hypothetical protein 
6.046543067 0.048071 
intergenic between 
FTL_0408 and FTL_0409   hypothetical protein 
6.086182237 0.0448537 
intergenic between 
FTL_1645 and FTL_1646     
6.152287936 0.02371267 
intergenic between 
FTL_1953 and FTL_1954   
conserved hypothetical 
membrane protein 
6.288269169 0.01915536 FTL_0568 isftu2 Transposase 
6.375452213 0.01503285 FTL_0496 thrB 
homoserine kinase 
(pseudogene) 
6.819971411 0.02007481 FTL_0474 lolC 
lipoprotein releasing 
system, subunit 
C,putative membrane 
protein 
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Table 2.  (Continued). 
7.238472409 0.01694981 FTL_0495 thrA 
bifunctional 
aspartokinase/homoserine 
dehydrogenase I 
(pseudogene) 
7.408171347 0.01997309 
intergenic between 
FTL_1589 and FTL_1590 msc 
mechanosensitive ion 
channel protein 
7.613734457 0.040795 FTL_1124   hypothetical protein 
7.906864993 0.02297458 FTL_1944; FTL_1925 isftu1 Transposase 
8.066832218 0.03184661 
19 base overlap with 
FTL_1648 oppF 
oligopeptide transporter, 
subunit F, ABC transporter, 
ATP-binding protein 
8.103479133 0.04138666 FTL_0562   
conserved hypothetical 
protein, pseudogene 
8.241788902 0.02430586 FTL_1280   
D-Beta-hydroxybutyrate 
dehydrogenase,psuedogene
8.871987933 0.03965435 FTL_0775 hsdR1 
Type I restriction enzyme 
subunit R, pseudogene 
9.181028537 0.00597319 
intergenic between 
FTL_1493 and FTL_1494   hypothetical protein 
9.303168779 0.03564467 FTL_0446   hypothetical protein 
9.721982075 0.03564467 FTL_1092 betT 
Betaine/carnitine/choline 
transporter (BCCT) family 
protein, pseudogene 
9.947699861 0.02475487 
intergenic between 
FTL_1336 and FTL_1337   
amino acid permease 
family protein, pseudogene
9.983033158 0.02700348 FTL_0323   
Smf protein DNA 
processing chain A, 
pseudogene 
10.09337723 0.0146488 FTL_1281   
D-Beta-hydroxybutyrate 
dehydrogenase,psuedogene
10.10298529 0.02050863 FTL_0501 speA 
putative arginine 
decarboxylase 
10.17116049 0.01625823 FTL_0446   hypothetical protein 
10.39217736 0.01860968 FTL_1770 pilT 
Type IV pili nucleotide-
binding protein 
10.74624435 0.03973755 FTL_0022 gabD1 
Succinate-semialdehyde 
dehydrogenase, fragment
12.4857256 0.01915536 FTL_0702   hypothetical protein 
13.11213182 0.02788963       
13.13737321 0.03099376 FTL_1767   
deoxyribodipyrimidine 
photolyase 
14.11177762 0.01262576 FTL_1944; FTL_1925 isftu1 Transposase 
15.11674799 0.03500214     hypothetical protein 
16.50777825 0.03973755 
67 base overlap with 
FTL_0634 naoX NADH oxidase 
17.7128157 0.04949982 FTL_1844   Secretion protein 
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SDS-PAGE analysis reveals a soluble protein deleted from the FTL0552 mutant. 
 In addition to gene microarray analysis, I used SDS-PAGE to compare protein 
expression of F. tularensis LVS parent strain and FTL0552 mutant.  Bacterial lysate and 
supernatant samples were run on two SDS-PAGE gels and stained with Coomassie 
Brilliant Blue and Silver Stain.  There was no observable difference between the two 
strains lysate or supernatant samples on the Coomassie Blue stained gel.  However, the 
more sensitive Silver Stain revealed a protein band, migrating between 25-30 kDa, from 
the supernatant fraction of the F. tularensis LVS parental strain that is absent in the 
FTL0552 mutant sample (Fig. 19).  Lowered production of a soluble protein in the 
FTL0552 mutant is not surprising given the number of genes identified as being regulated 
by FTL0552.  Survival of F. tularensis LVS within host cells depends on the bacteriums 
ability to have a mechanism which protects the bacteria from degradation by the host cell, 
allows escape from the phagosome, replication within the cytoplasm and signals the host 
cell to undergo apoptosis in order for the bacteria to be released and invade new cells.  
While several genes have been identified as being essential to the intracellular survival of 
F. tularensis, the mechanism has yet to be characterized.  Further analysis is required to 
identify the secreted proteins and their role in the interaction with the host cell.      
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Figure 19.  Silver Stain of F. tularensis LVS and FTL0552 mutant bacterial 
proteins.  Lane 1 Mult Mark protein ladder; Lane 2; media alone, Lanes 3 and 5; LVS 
wild type cleared lysate at 10µg and 20µg, Lanes 4 and 6; FTL0552 mutant cleared lysate 
at 10µg and 20µg, Lane 7; media alone, Lane 8; LVS wild type supernatant at 20µg, 
Lane 9; FTL0552 supernatant at 20µg. 
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Discussion 
 
It was the goal of this project to identify genes encoding potential two-component 
regulatory systems in the F. tularensis that may be involved in regulation of virulence 
factor genes.   In order to identify potential response-regulator genes that activate genes 
necessary for bacterial virulence, we searched the F. tularensis LVS genome using a 
consensus amino acid sequence derived from the phoP response-regulator genes from 
other Gram-negative bacteria.  One locus, FTL0552, was identified by the similarity of its 
protein product to the PhoP response-regulator consensus sequence.  The FTL0552 locus 
is 687 nucleotides in length and was annotated in the genome sequence as a 
transcriptional response-regulator.   The corresponding locus in F. tularensis Schu S4 
(FTT1557c) is highly conserved.  
 
In this report we describe the construction of a deletion mutant for FTL0552 in F. 
tularensis LVS.  The FTL0552 gene was interrupted with a kanR gene, replacing 
nucleotides 26-645.  A knockout mutant in the response-regulator gene (FTL0552) was 
constructed by combining PCR generated products delivered by conjugation, with 
subsequent recombination into the bacterial chromosome by allelic replacement.  F. 
tularensis LVS mutant deleted for FTL0552 was shown to be defective for survival in 
both mouse J774A.1 cells and peritoneal macrophages.   This mutant was completely 
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attenuated in both BALB/c and C57BL/6 mice at doses up to 1 X 105 CFU/ mouse.  
Challenge studies of mice surviving infection with the FTL0552 mutant using the virulent 
Schu S4 strain suggest that some level of protective immunity is afforded to these mice.   
Furthermore, mice infected with the FTL0552 mutant exhibited reduced levels of pro-
inflammatory cytokine production, and reduced evidence of histopathology in affected 
tissues, and correspondingly, reduced systemic infection and rapid clearance of the 
bacterium.   Our results support a major role for the FTL0552 gene product in controlling 
expression of virulence genes in F. tularensis.    
 
Despite identification of the genomic locus (FTL0552) encoding this gene by 
homology with a PhoP consensus sequence from other bacteria, it does not appear to 
function as a PhoP homologue.  While the poor intramacrophage survival and reduced 
virulence in mice are consistent with phoP mutants described in other bacteria (38), the 
growth rate was not significantly altered at low Mg2+ concentrations.  Low Mg2+ 
environments have been reported to result in slower growth for Salmonella phoP 
mutants, suggesting PhoP plays a role in regulating genes associated with Mg2+ transport, 
as well as increased susceptibility to hydrogen peroxide, and acidic pH (38, 88).   The F. 
tularensis FTL0552 mutant was not observed to exhibit either property.   Additionally, 
the absence of an adjacent gene on the F. tularensis genome sequence that is homologous 
to the sensor histidine kinase, phoQ, differs from the gene arrangement in other bacteria 
where phoP/phoQ forms a two-gene operon (38).  However, it is certainly possible that 
FTL0552 could form a two-component regulatory system with the product of an 
unknown gene located within another region of the F. tularensis chromosome.  At this 
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point, it is unclear if FTL0552 encodes a response-regulator that is part of a two-
component system.  Two loci sharing homology to PhoQ have been identified (FTL1878 
and FTL1762) and are being examined to determine if either gene is the cognate sensor 
histidine kinase functioning to activate FTL0552. 
 
FTL0552 protein is highly conserved among various Francisella strains including 
Francisella tularensis subsp. holarctica OSU18 (NC008369), Francisella tularensis 
subsp. tularensis FSC 198 (NC008245), and Francisella tularensis subsp. tularensis 
Schu S4 (NC006570).  When the deduced amino acid sequence derived from FTL0552 
was used in a BLAST search against all peptide and translated sequences in GenBank, 
the best hits were known or putative response-regulators.  Included in these hits was 
PmrA from Pseudomonas aeruginosa, the response-regulator part of the two-component 
regulatory system PmrA-PmrB.   PmrA is activated through PmrB and responds to 
extracellular iron and mild acid pH and confers resistance to polymyxin B and other 
antimicrobial peptides in Salmonella (50, 63, 92).   Functional PmrA is required to allow 
Salmonella to adapt to the toxic effects of high iron environments (92).   Since PmrA 
mutants in other bacteria are typically more susceptible to polymyxin B, we might expect 
the FTL0552 mutant to also be more susceptible to polymyxin B (92).   However, the 
initial selection of our FTL0552 mutant was performed in the presence of 100 µg/ml of 
polymyxin B suggesting that FTL0552 is not necessary to confer resistance to polymyxin 
B and does not function in the same manner as PmrA in other bacteria.  The FTL0552 
mutant was resistant to polymyxin B up to a concentration of 1000 µg/ml.  Thus, the  
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stimulus that is responsible for activating genes that are regulated by FTL0552 remains 
uncharacterized. 
 
The PmrA-PmrB system in Salmonella controls the transcription of several genes 
necessary for polymyxin B resistance and mediates the modification of LPS when 
induced by high iron or promoted by growth in low magnesium (39, 40, 50).  However, 
PmrA-activated genes stimulated by growth in low magnesium requires another two-
component system, PhoP-PhoQ (50).  Previous studies defined the genetic basis for the 
interaction between the PhoP-PhoQ and PmrA-PmrB systems that regulates expression of 
antimicrobial resistance determinants in response to two different environmental 
conditions (50).  In the presence of low magnesium, PhoP mediates transcription of the 
pmrD gene that mediates the transcriptional induction of PmrA-activated genes (50).  In 
the presence of excess iron, transcriptional activation of PmrA-activated genes is 
independent of PmrD, which controls the activity of the PmrA-PmrB system at a post-
transcriptional level (50).  A model for activation of the PmrA-PmrB system by the 
PhoP-PhoQ system is described by Gunn et al., 1998 (Fig. 20) (40, 50).  PhoQ serves as a 
magnesium sensor that modulates PhoP to activate the pmrD gene.  The interaction 
between PhoP-PhoQ and PmrA-PmrB in Salmonella is a novel type of interaction 
between a pair of two-component systems, affording the bacteria physiological plasticity 
in response to a broad spectrum of environmental conditions (50).  The ability of the 
FTL0552 mutant to retain polymyxin B resistance indicates that the gene does not 
function like PmrA of other bacteria.  However, the bacterium was exposed to polymyxin 
B under normal growth conditions.  Perhaps exposure to a high iron or low magnesium 
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environment would render the FTL0552 mutant sensitive to polymyxin B, due to the loss 
of activation of genes involved in LPS modification and polymyxin B resistance.  
However, a mutant in this gene in F. tularensis subsp. novicida (FNU663.2) was found to 
be sensitive to antimicrobial killing by polymyxin B but apparently not through the 
typical mechanism of LPS modification (Mohapatra, Soni et al. 2007).  This suggests that 
LVS FTL0552 and pmrA of F. tularensis subsp. novicida exhibit unique phenotypic 
properties and the stimuli responsible for activating FTL0552 remains uncharacterized. 
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Figure 20.  Model for the activation of the PmrAPmrB two-component system by 
the PhoPPhoQ two-component system.  Transcription of PmrA-activated genes can be 
induced by growth in high iron independently of the PhoPPhoQ two-component 
system (right) or by growth in low magnesium in a PhoPPhoQ-dependent manner (left). 
During growth in low magnesium, the PhoPPhoQ system promotes expression of the 
pmrD gene.  The PmrD protein controls the activity of the PmrAPmrB system at a post-
transcriptional level.  The seven-gene pbgP/E operon has also been designated the pmrF 
locus (adapted from Linda F.F. Kox, Marc M.S.M. Wösten, and Eduardo A. Groisman, 
2000).   
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 The gene encoding the FTL0552 response-regulator appears to be present as the 
first gene of a cluster of five genes.  The intergenic space between these genes is either 
extremely short or absent.  Some of the genes overlap with the putative start codon for 
truB located inside the reading frame for rnc and the start codon for rnr is inside the 
reading frame for truB.  Thus, it is unlikely that promoter and transcription termination 
sequences for each or any of these five genes are located inside this putative operon.   
RT-PCR analysis revealed that FTL0552 is transcribed as a five-gene operon.   The other 
genes included in this putative operon include signal peptidase I (lepB), ribonucleases 
(rnc, and rnr) and tRNA pseudouridine synthetase B (truB).   The five-gene arrangement 
is conserved in Francisella tularensis subsp. holarctica OSU18 (NC008369), Francisella 
tularensis subsp. tularensis FSC 198 (NC008245), and Francisella tularensis subsp. 
tularensis Schu S4 (NC006570).   While it may be possible that some of these genes (the 
ribonucleases) are involved in some aspect of gene regulation, it appears that they encode 
proteins with diverse functions. This unusual cluster of genes is suggestive of some type 
of recombination event early in the evolution of Francisella spp..  Interestingly, with the 
exception of FTL0552, the gene arrangement is conserved in Legionella spp.. 
 
A hallmark of F. tularensis infection is the bacteriums ability to invade and 
replicate within host macrophages.  Once adapted to the host target cells, the bacterium is 
able to vigorously multiply before the host can offer a protective immune response, and 
spread to various organs such as the liver and spleen (32, 34).  The host-derived response 
to the rapidly multiplying bacteria, results in severe organ damage and is primarily 
responsible for the high mortality associated with F. tularensis LVS in mice and F. 
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tularensis tularensis (Type A) in humans (34).  Mutations in genes encoding bacterial 
proteins associated with intracellular growth have been shown to result in attenuation of 
F. tularensis LVS (32, 34).  Our studies indicate that the FTL0552 mutant is defective in 
intracellular replication in macrophages.  These findings are corroborated by the studies 
performed in the mouse model.  The FTL0552 mutant is completely avirulent in the 
mouse model.  When boosted, 40% of the BALB/c mice that had been infected with the 
FTL0552 mutant survived subsequent challenge with the highly virulent Schu S4 strain.  
Therefore, the FTL0552 mutant is not only highly attenuated in mice, but also retains its 
antigenic potential and provides partial protection against virulent Schu S4 challenge.                    
 
The mutant exhibited reduced dissemination and decreased ability to induce 
histopathology in the target organ tissues.  Mice infected with the FTL0552 mutant were 
able to clear the bacteria much more efficiently than mice infected with the parental LVS 
strain.  Significantly lower numbers of bacteria disseminated to the spleen and were 
completely cleared by day 5.  After intranasal infection with the mutant strain, the mice 
were able to completely clear the bacteria from the lung by day 7.  The efficiency of 
clearance correlated with the reduced histopathology evident in the lung, liver and spleen 
of FTL0552 mutant infected mice, with the spleen appearing normal and no 
inflammatory changes observed.  Although some lesions and inflammation were 
observed in the liver and lung, there were very few, small lesions in these organs which 
was dramatically different from the parental LVS strain infected mice. 
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The mutant caused a reduced level of inflammatory cytokine production yet 
afforded partial protection to Schu S4 challenge.  The low levels of acute phase 
inflammatory cytokines from the FTL0552 infected lungs correlated with the low level of 
organ damage seen.  The increase in IL-12 indicates that a protective immune response 
was induced and is a very promising finding for developing a vaccine that is protective 
against F. tularensis.  Of note, treatment of mice with IL-12 has previously been shown 
to induce significant protection against the lethal respiratory tularemia (20). 
 
DNA microarray analysis identified 148 genes regulated by FTL0552 in F. 
tularensis LVS.  Of the genes identified, 75% were activated by FTL0552 and 1/3 of the 
genes repressed by FTL0552 were hypothetical proteins.  The genes that are up regulated 
by the FTL0552 mutant include pseudogenes, two transposases, and, interestingly, the 
gene encoding a type IV pili nucleotide-binding protein, pilT.  Among the 113 genes 
activated by FTL0552 are the intracellular growth locus genes found within the FPI, iglA, 
iglB, iglC and iglD.  These genes have been shown to be essential for infection and 
survival within macrophages (34, 54, 58, 65).  In addition, FTL0552 was shown to 
activate genes encoding a macrophage infectivity potentiator, type IV pili fiber building 
block protein, the transport protein (ampG), the outer membrane protein (fopA), and the 
sodB gene.  The type IV pili fiber building block protein is involved in the bacteriums 
ability to attach and invade host cells and the loss of expression of this gene is likely to 
result in a defect in the bacterias ability to infect macrophages, as seen in the FTL0552 
mutant.  The sodB gene has been shown to play a role in virulence of F. tularensis LVS 
(6).  F. tularensis LVS SodB mutants were attenuated for virulence in mice.   
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The loss of expression of these genes is likely to play a role in the impaired intracellular 
survival and the attenuated virulence in mice observed by the FTL0552 mutant.   
 
The presence of orphaned members of TCS in Francisella tularensis represents a 
unique phenomenon of virulence regulation to allow for the survival and persistence of 
this bacterium within a variety of environments.  The lack of the typical TCS 
arrangement could be the result of evolutionary changes and the presence of five 
insertion elements scattered throughout the genome (58).  The genetic basis of F. 
tularensis pathogenesis is poorly understood and only beginning to be studied.  The 
recent advancements in genetic tools to manipulate F. tularensis has offered the 
Francisella community opportunities for making specific mutations and studying the 
bacteria at the genetic level that has, until now, hindered the progression of research in 
this area, particularly for type A and type B strains. 
 
In summary, we have described a strain of F. tularensis LVS that is deleted for 
FTL0552 encoding a putative response-regulator.  This mutant is defective for replication 
in macrophages and is avirulent in the mouse model.    Although the phenotypic 
properties observed in the FTL0552 mutant are inconsistent with PhoP of other bacteria, 
it clearly plays a role in regulation of virulence genes in F. tularensis LVS.  Perhaps, as 
an orphan response-regulator, FTL0552 works in trans with other regulatory proteins to 
exert its effect.  Identification of a sensor histidine kinase responsible for the activation of 
FTL0552 could provide insight into the environmental signaling cues that modulate the 
activity of this gene.  Two loci sharing homology with PhoQ were identified by searching 
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the database with a derived PhoQ consensus sequence from other gram negative bacteria 
(FTL1762 and FTL1878).  The genes are identified as a sensor histidine kinase (qseA) 
and a two-component sensor protein (kdpD).  QseA is the quorum sensing Escherichia 
coli regulator A and KdpD is the sensor kinase in the two-component regulatory system, 
KdpD-KdpE, responsible for regulating intracellular K+ in E. coli.  Although most two-
component sensor kinases are specific for activation of their cognate response-regulator, 
it is possible evolution has forced some bacteria to adapt by programming sensor kinases 
to respond to more than one environmental cue and act on more than one response-
regulator to exert a coordinated response for survival.  This could explain the 
inconsistencies with the phenotypic properties of FTL0552 and the lack of a typical 
cognate sensor kinase.  Identifying the environmental cues leading to activation of 
FTL0552 will provide insight into the protein interaction leading to FTL0552 activation 
and modulation of virulence genes.   
 
Currently, the data presented supports the role of FTL0552 in regulation of 
virulence in F. tularensis LVS and provides an opportunity for investigation of the effects 
of an FTT1557c mutant in F. tularensis subsp. tularensis for evaluation as a possible 
vaccine candidate.   Such a mutant may form the basis of a defined live attenuated 
vaccine that affords protection in humans against more virulent type A strains.   
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